Patent Publication Number: US-2023134686-A1

Title: Compositions containing benzoic acid or furoic acid derivatives and use of the derivatives for emulsion and foam stability

Description:
FIELD OF INVENTION 
     The present invention belongs to the area of cosmetics and refers to new compositions with improved stability comprising selected additives. 
     STATE OF THE ART 
     Typically, cosmetic compositions comprise a multitude of components. Looking at the listing of ingredients for an average night cream one can find up to 20 positions and there has been a tendency to add as many ingredients as possible in order to address many different issues, all at the same time. As a matter of fact, many consumers equal complexity of a composition with benefit and are accepting high prices, since (s)he expects also high performance. On the other hand, the more complex a composition becomes, the more difficult it is to avoid negative interactions between the components. A major problem for cosmetic compositions, of course in particular for all types of emulsions, is still their stability, especially in case they are subjected to difficult storage conditions, like high or low temperatures. 
     Another object is related to the sensorial profile. Spreadability, afterfeel and smell are important parameters contributing to the overall liking of a cosmetic formulation after application to skin: 
     The faster the oil bodies of an emulsion are spread on the skin the better is the perception of the customer. The spreading behaviour of a formulation—and therefore its sensorial profile—is linked to the average particle size of the droplets in the composition. The smaller the droplets are, the faster the spreading is. As a consequence, there is still a need for additives allowing to shift the average particle size distribution to lower values. 
     Another problem especially for shampoo compositions is foam stability. 
     In this context reference is made to the following documents: 
     WO 90/00859 A1 (NELSON &amp; ROBERTSON) discloses insect repellent bar soap compositions including specific insect repellent agents. According to the invention, these agents are used at an amount of 18 to 20% by weight based on the total weight of the composition. 1,3-propandiol monobenzoate is claimed as one example of insect repellent that can be used. No stabilizing properties of 1,3-propandiol monobenzoate is mentioned and no formulation of an emulsion type is described throughout the patent. Also formulations of shampoo or liquid soap type are not disclosed. 
     WO 2007/137128 A1 (MARY KAY) reveals topical compositions for skin care comprising glyceryl salicylates to reduce moisture evaporation from skin, protect skin from UV light, and treat aged or damaged skin. Propylene glycol monobenzoate is proposed as one of the ingredients. No stabilizing properties of the different ingredients are described. In addition, propylene glycol monobenzoate is not described are not mentioned in the context of a formulation, such as emulsion or shampoo/liquid soap. 
     US 2016/0000066 A1 (RHODIA OPERATIONS) disclose furfural derivatives as solvents for plant protection products and/or resins. One of the claimed furfural derivatives is furoic acid hydroxypropyl ester. No reference is made to cosmetic products or products to be applied topically or systemically to humans or animals and no compositions are provided that resemble cosmetic products in any aspect. Furthermore, this document is silent with regard to stabilizing properties of the furfural derivatives and in particular furoic acid hydroxypropyl ester. 
     Different documents refer to the chemical synthesis of anisic acid-3-hydroxypropyl ester [JOURNAL OF THE KOREAN CHEMICAL SOCIETY, 2002, 46(5), 479-485; SYNTHESIS, 2003, (15), 2373-2377]. However, no indication on specific use or benefits of the synthesized product is given. In particular, no reference is made to cosmetic use or use as an agent with stabilizing properties. 
     None of these references disclose or even refer to the problems explained above. 
     Therefore, the object of the present invention has been to identify a multi-functional additive for cosmetic formulations, which does not negatively interact with other ingredients while improving the stability and the sensorial profile of the cosmetic compositions containing this additive. 
    
    
     DESCRIPTION OF THE INVENTION 
     The object of the present invention is directed to a composition, preferably a cosmetic composition, comprising or consisting of
     (a) at least one compound of formula (I) or salt thereof   

     
       
         
         
             
             
         
       
     
     wherein 
     X denotes CH═CH or CZ1═CZ2, wherein
         if Z1 is H then Z2 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt, and   if Z2 is H then Z1 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2  OMe and OEt,       

     Y denotes a radical selected from the group consisting of NH 2  NHMe, NMe 2 , NHEt, O—(CH 2 ) n —OH, wherein n is 2 to 5, and 
     R denotes a radical selected from the group consisting of H, OH, Me, Et, OMe, OEt, NH 2 , NHMe, NMe 2 , NHEt and NEt 2,    
     or 
     X denotes O, 
     Y denotes a radical selected from the group consisting of NH 2 , NHMe, NMe 2 , NHEt, O—(CH 2 ) n —OH and OMe wherein n is 2 to 5 and 
     R denotes H, OH, Me, Et, OMe, OEt, NH 2 , NHMe, NMe 2 , NHEt, NEt 2    
     (b) at least one oil body or wax, and/or 
     (c) at least one emulsifier and optionally 
     (d) at least one active principle. 
     Surprisingly it has been observed that compounds of formula (I) serve all the above mentioned needs simultaneously:
         adjunction of the compounds of formula (I) improves the stability of cosmetic formulations even under difficult storage conditions, and   at the same time, adjunction of the compounds in a cosmetic formulation improve its sensorial profile. In particular, the compounds lead to the formation of smaller droplets in the compositions. Due to the fact the oil or water droplets more finely divided, the sensation on skin is improved. For example, the greasy afterfeel of creams and lotions can be reduced in that way. The deodorants can also have a smoother feeling and a more creamy feeling when applied to the skin;   furthermore, it has been observed that said compounds of formula (I) improve foam stability of shampoo.       

     Therefore, the compounds of formula (I) serve the need for so-called “true multi-tasking ingredients”. 
     To avoid ambiguities it should be noted that in case reference is made to “a compound” this also encompasses a disclosure for more than one compound, namely also mixtures. 
     COMPOUNDS OF FORMULA I 
     Compounds of Formula (I) 
     
       
         
         
             
             
         
       
     
     As explained above, are known from the state of the art; reference is made to the documents mentioned above. 
     Notwithstanding this fact, the specific properties of these compounds as claimed by the present invention have not been identified or disclosed before. With regard to the improvement in emulsion stability increase, compounds of formula (I) or a salt thereof are particular preferred wherein 
     X denotes O, CH═CH or CZ1|CZ2, wherein
         if Z1 is H then Z2 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt, and   if Z2 is H then Z1 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt,       

     Y denotes a radical selected from the group consisting of NH 2 , NHMe, NMe 2 , NHEt, O—(CH 2 ) n —OH, wherein n is 2 to 3, and 
     R denotes a radical selected from the group consisting of H, OH, Me, Et, OMe, OEt, NH 2 , NHMe, NMe 2 , NHEt and NEt 2 . 
     Another preferred embodiment of the present invention refers to compounds of formula (I) or a salt thereof wherein 
     X denotes O, CH═CH or CZ1|CZ2, wherein
         if Z1 is H then Z2 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt, and   if Z2 is H then Z1 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt,       

     Y denotes O—(CH 2 ) n —OH, wherein n is 2 to 3, and 
     R denotes a radical selected from the group consisting of H, OH, Me, Et, OMe, OEt, NH 2 , NHMe, NMe 2 , NHEt and NEt 2 . 
     Another preferred embodiment of the present invention refers to compounds of formula (I) or a salt thereof wherein 
     X denotes CH═CH or CZ1|CZ2, wherein
         if Z1 is H then Z2 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt, and   if Z2 is H then Z1 denotes a radical selected from the group consisting of OH, NH 2 , NHMe, NMe 2 , OMe and OEt,       

     Y denotes O—(CH 2 ) n —OH, wherein n is 2 to 3, and 
     R denotes a radical selected from the group consisting of H, OH, Me, Et, OMe, OEt, NH 2 , NHMe, NMe 2 , NHEt and NEt 2 . 
     Particularly preferred compounds of formula (I) are: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
     Oil Bodies 
     Suitable oil bodies (component b1), are, for example, Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10, carbon atoms, esters of linear C 6 -C 22 -fatty acids with linear or branched C 6 -C22-fatty alcohols or esters of branched C 6 -C 13-carboxylic acids with linear or branched C 6 -C 22 -fatty alcohols, such as, for example, myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myristyl oleate, myristyl behenate, myristyl erucate, cetyl myristate, cetyl palmitate, cetyl stearate, cetyl isostearate, cetyl oleate, cetyl behenate, cetyl erucate, stearyl myristate, stearyl palmitate, stearyl stearate, stearyl isostearate, stearyl oleate, stearyl behenate, stearyl erucate, isostearyl myristate, isostearyl palmitate, isostearyl stearate, isostearyl isostearate, isostearyl oleate, isostearyl behenate, isostearyl oleate, oleyl myristate, oleyl palmitate, oleyl stearate, oleyl isostearate, oleyl oleate, oleyl behenate, oleyl erucate, behenyl myristate, behenyl palmitate, behenyl stearate, behenyl isostearate, behenyl oleate, behenyl behenate, behenyl erucate, erucyl myristate, erucyl palmitate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate and erucyl erucate. Also suitable are esters of linear C 6 -C 22 -fatty acids with branched alcohols, in particular 2-ethylhexanol, esters of C 18 -C38-alkylhydroxy carboxylic acids with linear or branched C 6 -C 22 -fatty alcohols, in particular Dioctyl Malate, esters of linear and/or branched fatty acids with polyhydric alcohols (such as, for example, propylene glycol, dimerdiol or trimertriol) and/or Guerbet alcohols, triglycerides based on C6 -Cm-fatty acids, liquid mono-/di-/triglyceride mixtures based on C 6 -C H -fatty acids, esters of C 6 -C 22 -fatty alcohols and/or Guerbet alcohols with aromatic carboxylic acids, in particular benzoic acid, esters of C 2 -C 12 -dicarboxylic acids with linear or branched alcohols having 1 to 22 carbon atoms or polyols having 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched C 6 -C 22 -fatty alcohol carbonates, such as, for example, Dicaprylyl Carbonate (Cetiol® CC), Guerbet carbonates, based on fatty alcohols having 6 to 18, preferably 8 to 10, carbon atoms, esters of benzoic acid with linear and/or branched C 6 -C 22 -alcohols (e.g. Finsolv® TN), linear or branched, symmetrical or asymmetrical dialkyl ethers having 6 to 22 carbon atoms per alkyl group, such as, for example, dicaprylyl ether (Cetiol® OE), ring-opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicones, silicone methicone grades, etc.), aliphatic or naphthenic hydrocarbons, such as, for example, squalane, squalene or dialkylcyclohexanes, and/or mineral oils. 
     WAXES 
     Among the group of suitable waxes (component b2) one can differentiate between the following types: 
     superfatting agents 
     consistency factors 
     pearlising waxes, and 
     natural waxes 
     Superfatting agents. Superfatting agents may be selected from substances such as for example, lanolin and lecithin and also polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides; fatty acid alkanolamides can also serve as foam stabilizers. 
     Consistency factors. The consistency factors can be for example fatty alcohols or hydroxyfatty alcohols containing 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids of the same carbon range. A combination of these substances with alkyl oligoglucosides and/or fatty acid N-methyl glucamides of the same chain length and/or polyglycerol poly-12-hydroxystearates is preferably used. 
     Pearlising waxes. Suitable pearlising waxes are, for example, alkylene glycol esters, especially ethylene glycol distearate; fatty acid alkanolamides, especially cocofatty acid diethanolamide; partial glycerides, especially stearic acid monoglyceride; esters of polybasic, optionally hydroxysubstituted carboxylic acids with fatty alcohols containing 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; fatty compounds, such as for example fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates which contain in all at least 24 carbon atoms, especially laurone and distearylether; fatty acids, such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides containing 12 to 22 carbon atoms with fatty alcohols containing 12 to 22 carbon atoms and/or polyols containing 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof. 
     Natural waxes. Besides natural oils used, waxes may also be present in the preparations, more especially natural waxes such as, for example, candelilla wax, carnauba wax, Japan wax, espartograss wax, cork wax, guaruma wax, rice oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, spermaceti, lanolin (wool wax), uropygial fat, ceresine, ozocerite (earth wax), petrolatum, paraffin waxes and microwaxes; chemically modified waxes (hard waxes) such as, for example, montan ester waxes, sasol waxes, hydrogenated jojoba waxes and synthetic waxes such as, for example, polyalkylene waxes and polyethylene glycol waxes. 
     EMULSIFIERS 
     As an optional, the compositions according to the present invention may also include emulsifiers (component c). The emulsifiers may be of non-ionic, anionic, cationic and/or amphoteric nature. 
     In particular preferred are non-ionic emulsifiers, such as:
     products of the addition of 2 to 30 mol ethylene oxide and/or 0 to 5 mol propylene oxide onto linear C8-22 fatty alcohols, onto C12-22 fatty acids and onto alkyl phenols containing 8 to 15 carbon atoms in the alkyl group;   C 12/18  fatty acid monoesters and diesters of addition products of 1 to 30 mol ethylene oxide onto glycerol;   glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsaturated fatty acids containing 6 to 22 carbon atoms and ethylene oxide addition products thereof;   addition products of 15 to 60 mol ethylene oxide onto castor oil and/or hydrogenated castor oil;   polyol esters and, in particular, polyglycerol esters such as, for example, polyglycerol polyricinoleate, polyglycerol poly-12-hydroxystearate or polyglycerol dimerate isostearate. Mixtures of compounds from several of these classes are also suitable;   addition products of 2 to 15 mol ethylene oxide onto castor oil and/or hydrogenated castor oil;   partial esters based on linear, branched, unsaturated or saturated C 6/22  fatty acids, ricinoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, pentaerythritol, dipentaerythritol, sugar alcohols (for example sorbitol), alkyl glucosides (for example methyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides (for example cellulose);   mono-, di and trialkyl phosphates and mono-, di- and/or tri-PEG-alkyl phosphates and salts thereof;   wool wax alcohols;   polysiloxane/polyalkyl polyether copolymers and corresponding derivatives;   mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol and/or mixed esters of C 6-22  fatty acids, methyl glucose and polyols, preferably glycerol or polyglycerol, polyalkylene glycols and   glycerol carbonate.   

     The addition products of ethylene oxide and/or propylene oxide onto fatty alcohols, fatty acids, alkylphenols, glycerol mono- and diesters and sorbitan mono- and diesters of fatty acids or onto castor oil are known commercially available products. They are homologue mixtures of which the average degree of alkoxylation corresponds to the ratio between the quantities of ethylene oxide and/or propylene oxide and substrate with which the addition reaction is carried out. C 12/18  fatty acid monoesters and diesters of addition products of ethylene oxide onto glycerol are known as lipid layer enhancers for cosmetic formulations. The most preferred emulsifiers are described in more detail as follows: 
     Partial glycerides. Typical examples of suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid monoglyceride, isostearic acid diglyceride, oleic acid monoglyceride, oleic acid diglyceride, ricinoleic acid monoglyceride, ricinoleic acid diglyceride, linoleic acid monoglyceride, linoleic acid diglyceride, linolenic acid monoglyceride, linolenic acid diglyceride, erucic acid monoglyceride, erucic acid diglyceride, tartaric acid monoglyceride, tartaric acid diglyceride, citric acid monoglyceride, citric acid diglyceride, malic acid monoglyceride, malic acid diglyceride and technical mixtures thereof which may still contain small quantities of triglyceride from the production process. Addition products of 1 to 30 and preferably 5 to 10 mol ethylene oxide onto the partial glycerides mentioned are also suitable. 
     Sorbitan esters. Suitable sorbitan esters are sorbitan monoisostearate, sorbitan sesquiisostea rate, sorbitan diisostea rate, sorbitan triisostea rate, sorbitan monooleate, sorbitan sesquioleate, sorbitan dioleate, sorbitan trioleate, sorbitan monoerucate, sorbitan sesquierucate, sorbitan dierucate, sorbitan trierucate, sorbitan monoricinoleate, sorbitan sesquiricinoleate, sorbitan diricinoleate, sorbitan triricinoleate, sorbitan monohydroxystearate, sorbitan sesquihydroxystearate, sorbitan dihydroxystearate, sorbitan trihydroxystearate, sorbitan monotartrate, sorbitan sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan dicitrate, sorbitan tricitrate, sorbitan monomaleate, sorbitan sesquimaleate, sorbitan dimaleate, sorbitan trimaleate and technical mixtures thereof. Addition products of 1 to 30 and preferably 5 to 10 mol ethylene oxide onto the sorbitan esters mentioned are also suitable. 
     Polyglycerol esters. Typical examples of suitable polyglycerol esters are Polyglyceryl-2 Dipolyhydroxystearate (Dehymuls® PGPH), Polyglycerin-3-Diisostearate (Lameform® TGI), Polyglyceryl-4 Isostearate (Isolan® GI 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera BeMina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010/90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403), Polyglyceryl Dimerate Isostearate and mixtures thereof. Examples of other suitable polyolesters are the mono-, di- and triesters of trimethylol propane or pentaerythritol with lauric acid, cocofatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like optionally reacted with 1 to 30 mol ethylene oxide. 
     Anionic emulsifiers. Typical anionic emulsifiers are aliphatic C12-22 fatty acids, such as palmitic acid, stearic acid or behenic acid for example, and C12-22 dicarboxylic acids, such as aze laic acid or sebacic acid for example. 
     Amphotheric or zwitterionic emulsifiers. Other suitable emulsifiers are amphoteric or zwitterionic surfactants. Zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N,N-dimethyl ammonium glycinates, for example cocoalkyl dimethyl ammonium glycinate, N-acylaminopropyl-N,N-dimethyl ammonium glycinates, for example cocoacylaminopropyl dimethyl ammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl imidazolines containing 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate. The fatty acid amide derivative known under the CTFA name of Cocamidopropyl Betaine is particularly preferred. Ampholytic surfactants are also suitable emulsifiers. Ampholytic surfactants are surface-active compounds which, in addition to a C 8/18  alkyl or acyl group, contain at least one free amino group and at least one —COOH— or —SO 3 H— group in the molecule and which are capable of forming inner salts. Examples of suitable ampholytic surfactants are N-alkyl glycines, N-alkyl propionic acids, N-alkylanninobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropyl glycines, N-alkyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids containing around 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C 12/18  acyl sarcosine. 
     Active Principles 
     The compositions according to the present invention may contain additional ingredients (component d) encompassed by the term “active principles”. Examples for suitable ingredients are abrasives, anti-acne agents, agents against ageing of the skin, anti-cellulitis agents, antidandruff agents, anti-inflammatory agents, irritation-preventing agents, irritation-inhibiting agents, antioxidants, astringents, perspiration-inhibiting agents, antiseptic agents, antstatics, binders, buffers, carrier materials, chelating agents, cell stimulants, cleansing agents, care agents, depilatory agents, surface-active substances, deodorizing agents, antiperspirants, softeners, enzymes, essential oils, fibres, film-forming agents, fixatives, foam-forming agents, foam stabilizers, substances for preventing foaming, foam boosters, gelling agents, gel-forming agents, hair care agents, hair-setting agents, hair-straightening agents, moisture-donating agents, moisturizing substances, moisture-retaining substances, bleaching agents, strengthening agents, stain-removing agents, optically brightening agents, impregnating agents, dirtrepellent agents, friction-reducing agents, lubricants, moisturizing creams, ointments, opacifying agents, plasticizing agents, covering agents, polish, gloss agents, polymers, powders, proteins, re-oiling agents, abrading agents, silicones, skin-soothing agents, skin-cleansing agents, skin care agents, skin-healing agents, skin-lightening agents, skin-protecting agents, skin-softening agents, hair promotion agents, cooling agents, skin-cooling agents, warming agents, skin-warming agents, stabilizers, UV-absorbing agents, UV filters, detergents, fabric conditioning agents, suspending agents, skin-tanning agents, thickeners, vitamins, oils, waxes, fats, phospholipids, saturated fatty acids, mono- or polyunsaturated fatty acids, a-hydroxy acids, polyhydroxyfatty acids, liquefiers, dyestuffs, colour-protecting agents, pigments, anti-corrosives, aromas, flavouring substances, odoriferous substances, polyols, surfactants, electrolytes, organic solvents or silicone derivatives and the like as additional auxiliaries and additives. 
     Thickening Agents and Rheology Additives 
     Suitable thickeners are polymeric thickeners, such as Aerosil® types (hydrophilic silicas), polysaccharides, more especially xanthan gum, guar-guar, agar-agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, also relatively high molecular weight polyethylene glycol monoesters and diesters of fatty acids, polyacrylates (for example Carbopols® [Goodrich] or Synthalens® [Sigma]), polyacrylamides, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols, for example pentaerythritol or trimethylol propane, narrow-range fatty alcohol ethoxylates and electrolytes, such as sodium chloride and ammonium chloride. 
     Polymers 
     Suitable cationic polymers are, for example, cationic cellulose derivatives such as, for example, the quaternized hydroxyethyl cellulose obtainable from Amerchol under the name of Polymer JR 400®, cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinyl pyrrolidone/vinyl imidazole polymers such as, for example, Luviquat® (BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides such as, for example, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen (Lamequat® L, Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as, for example, amodimethicone, copolymers of adipic acid and dimethylaminohydroxypropyl diethylenetriamine (Cartaretine®, Sandoz), copolymers of acrylic acid with dimethyl diallyl ammonium chloride (Merquat® 550, Chemviron), polyaminopolyamides and crosslinked water-soluble polymers thereof, cationic chitin derivatives such as, for example, quaternized chitosan, optionally in microcrystalline distribution, condensation products of dihaloalkyls, for example dibromobutane, with bis-dialkylamines, for example bis-dinnethylannino-1,3-propane, cationic guar gum such as, for example, Jaguar®CBS, Jaguar®C-17, Jaguar®C-16 of Celanese, quaternized ammonium salt polymers such as, for example, Mirapor®A-15, Mirapol®AD-1, Mirapol® AZ-1 of Miranol and the various polyquaternium types (for example 6, 7, 32 or 37) which can be found in the market under the tradenames Rheocare® CC or Ultragel® 300. 
     Suitable anionic, zwitterionic, amphoteric and nonionic polymers are, for example, vinyl acetate/crotonic acid copolymers, vinyl pyrrolidone/vinyl acrylate copolymers, vinyl acetate/butyl maleate/isobornyl acrylate copolymers, methyl vinylether/maleic anhydride copolymers and esters thereof, uncrosslinked and polyol-crosslinked polyacrylic acids, acrylamidopropyl trimethylammonium chloride/acrylate copolymers, octylacrylamide/methyl methacrylate/tert.-butylaminoethyl methacrylate/2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, vinyl pyrrolidone/dimethylaminoethyl methacrylate/vinyl caprolactam terpolymers and optionally derivatized cellulose ethers and silicones. 
     Silicones 
     Suitable silicone compounds are, for example, dimethyl polysiloxanes, methylphenyl polysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and/or alkyl-modified silicone compounds which may be both liquid and resin-like at room temperature. Other suitable silicone compounds are simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates. A detailed overview of suitable volatile silicones can be found in Todd et al. in Cosm. Toil. 91, 27 (1976). 
     Primary Sun Protection Factors 
     Primary sun protection factors in the context of the invention are, for example, organic substances (light filters) which are liquid or crystalline at room temperature and which are capable of absorbing ultraviolet radiation and of releasing the energy absorbed in the form of longer-wave radiation, for example heat. 
     The formulations according to the invention advantageously contain at least one UV-A filter and/or at least one UV-B filter and/or a broadband filter and/or at least one inorganic pigment. Formulations according to the invention preferably contain at least one UV-B filter or a broadband filter, more particularly preferably at least one UV-A filter and at least one UV-B filter. 
     Preferred cosmetic compositions, preferably topical formulations according to the present invention comprise one, two, three or more sun protection factors selected from the group consistiung of 4-aminobenzoic acid and derivatives, salicylic acid derivatives, benzophenone derivatives, dibenzoylnnethane derivatives, diphenyl acrylates, 3-imidazol-4-yl acrylic acid and esters thereof, benzofuran derivatives, benzylidene malonate derivatives, polymeric UV absorbers containing one or more organosilicon radicals, cinnamic acid derivatives, camphor derivatives, trianilino-s-triazine derivatives, 2-hydroxyphenylbenzotriazole derivatives, phenylbenzimidazole sulfonic acid derivatives and salts thereof, anthranilic acid menthyl esters, benzotriazole derivativesand indole derivatives. 
     In addition, it is advantageous to combine compounds of formula (I) with active ingredients which penetrate into the skin and protect the skin cells from inside against sunlightinduced damage and reduce the level of cutaneous matrix metalloproteases. Preferred respective ingredients, so called arylhydrocarbon receptor antagonists, are described in WO 2007/128723, incorporated herein by reference. Preferred is 2-benzylidene-5,6-dimethoxy3,3-dimethylindan-1-one. 
     The UV filters cited below which can be used within the context of the present invention are preferred but naturally are not limiting. 
     UV filters which are preferably used are selected from the group consisting of
     p-aminobenzoic acid   p-aminobenzoic acid ethyl ester (25 mol) ethoxylated (INCI name: PEG-25 PABA)   p-dimethylaminobenzoic acid-2-ethylhexyl ester   p-aminobenzoic acid ethyl ester (2 mol) N-propoxylated   p-aminobenzoic acid glycerol ester   salicylic acid homomenthyl ester (homosalates) (Neo Heliopan®HMS)   salicylic acid-2-ethylhexyl ester (Neo Heliopan®OS)   triethanolamine salicylate   4-isopropyl benzyl salicylate   anthranilic acid menthyl ester (Neo Heliopan®MA)   diisopropyl cinnamic acid ethyl ester   p-methoxycinnamic acid-2-ethylhexyl ester (Neo Heliopan®AV)   diisopropyl cinnamic acid methyl ester   p-methoxycinnamic acid isoamyl ester (Neo Heliopan®E 1000)   p-methoxycinnamic acid diethanolamine salt   p-methoxycinnamic acid isopropyl ester   2-phenylbenzimidazole sulfonic acid and salts (Neo Heliopan®Hydro)   3-(4′-trimethylammonium) benzylidene bornan-2-one methyl sulfate   beta-imidazole-4(5)-acrylic acid (urocanic acid)   3-(4′-sulfo)benzylidene bornan-2-one and salts   3-(4′-methyl benzylidene)-D,L-camphor (Neo Heliopan®MBC)   3-benzylidene-D,L-camphor   N-[(2 and 4)-[2-(oxoborn-3-ylidene) methyl]benzyl] acrylamide polymer   4,4′-[(6-[4-(1,1-dimethyl)aminocarbonyl) phenylamino]-1,3,5-triazine-2,4-diyl)diimino]-bis-(benzoic acid-2-ethylhexyl ester) (Uvasorb® HEB)   benzylidene malonate polysiloxane (Parsol®SLX)   glyceryl ethylhexanoate dimethoxycinnamate   dipropylene glycol salicylate   tris(2-ethyl hexyl)-4,4′,4″-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate (=2,4,6-trianilino-(p-carbo-2′-ethylhexyl-1′-oxy)-1,3,5-triazine) (Uvinul®T150)   

     Broadband filters which are preferably combined with one or more compounds of formula (I) in a preparation according to the present invention are selected from the group consisting of
     2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (Neo Heliopan®303)   ethyl-2-cyano-3,3′-diphenyl acrylate   2-hydroxy-4-methoxybenzophenone (Neo Heliopan®BB)   2-hydroxy-4-methoxybenzophenone-5-sulfonic acid   dihydroxy-4-methoxybenzophenone   2,4-dihydroxybenzophenone   tetrahydroxybenzophenone   2,2′-dihydroxy-4,4′-dimethoxybenzophenone   2-hydroxy-4-n-octoxybenzophenone   2-hydroxy-4-methoxy-4′-methyl benzophenone   sodium hydroxymethoxybenzophenone sulfonate   disodium-2,2′-dihydroxy-4,4′-dimethoxy-5,5′-disulfobenzophenone   phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3(1,3,3,3-tetramethyl-1-(trime-thylsilyl)oxy)disiloxyanyl)propyl) (Mexoryl®XL)   2,2′-methylene bis-(6-(2H-benzotriazol-2-yl)-4-1,1,3,3-tetramethylbutyl) phenol) (Tinosorb® M)   2,4-bis-[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-1,3,5-triazine   2,4-bis-[{(4-(2-ethylhexyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine (Tinosorb®S)   2,4-bis-[{(4-(3-sulfonato)-2-hydroxypropyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine sodium salt   2,4-bis-[{(3-(2-propyloxy)-2-hydroxypropyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine   2,4-bis-[{4-(2-ethylhexyloxy)-2-hydroxy}phenyl]-6-[4-(2-methoxyethyl carbonyl) phenylamino]-1,3,5-triazine   2,4-bis-[{4-(3-(2-propyloxy)-2-hydroxypropyloxy)-2-hydroxy}phenyl]-6-[4-(2-ethylcarboxyl)phenylamino]-1,3,5-triazine   2,4-bis-[{4-(2-ethylhexyloxy)-2-hydroxy}phenyl]-6-(1-methylpyrrol-2-yl)-1,3,5-triazine   2,4-bis-[{4-tris-(trimethylsiloxysilylpropyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine   2,4-bis-[{4-(2″-methylpropenyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine   2,4-bis-[{4-(1′,1′,1′,3′,5′,5′,5′-heptamethylsiloxy-2″-methylpropyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine   

     UV-A filters filters which are preferably combined with one or more compounds of formula (I) in a preparation according to the present invention are selected from the group consisting of
     4-isopropyl dibenzoyl methane   terephthalylidene dibornane sulfonic acid and salts (Mexoryl®SX)   4-t-butyl-4′-methoxydibenzoyl methane (avobenzone)/(Neo Heliopan®357)   phenylene bis-benzimidazyl tetrasulfonic acid disodium salt (Neo Heliopan®AP)   2,2′-(1,4-phenylene)-bis-(1H-benzimidazole-4,6-disulfonic acid), monosodium salt   2-(4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester (Uvinul® A Plus)   indanylidene compounds in accordance with DE 100 55 940 A1 (=WO2002 038537 A1)   

     UV filters which are more preferably combined with one or more compounds of formula (I) in a preparation according to the present invention are selected from the group consisting of
     p-aminobenzoic acid   3-(4′-trimethylammonium) benzylidene bornan-2-one methyl sulfate   salicylic acid homomenthyl ester (Neo Heliopan®HMS)   2-hydroxy-4-methoxybenzophenone (Neo Heliopan® 1313)   2-phenylbenzimidazole sulfonic acid (Neo Heliopan® Hydro)   terephthalylidene dibornane sulfonic acid and salts (Mexoryl®SX)   4-tert-butyl-4′-methoxydibenzoyl methane (Neo Heliopan® 357)   3-(4′-sulfo)benzylidene bornan-2-one and salts   2ethylhexyl-2-cyano-3,3-diphenyl acrylate (Neo Heliopan®303)   N-[(2 and 4)-[2-(oxoborn-3-ylidene) methyl]benzyl] acrylamide polymer   p-methoxycinnamic acid-2-ethylhexyl ester (Neo Heliopan®AV)   p-aminobenzoic acid ethyl ester (25 mol) ethoxylated (INCI name: PEG-25 PABA)   p-methoxycinnamic acid isoamyl ester (Neo Heliopan®E1000)   2,4,6-trianilino-(p-carbo-2′-ethylhexyl-1′-oxy)-1,3,5-triazine (Uvinul®T150)   phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3(1,3,3,3-tetramethyl-1-(trime-thylsilyl)oxy)disiloxyanyl)propyl) (Mexoryl® XL)   4,4′-[(6-[4-(1,1-dimethyl)aminocarbonyl) phenylamino]-1,3,5-triazine-2,4-diyl)diimino]-bis-(benzoic acid-2-ethylhexyl ester) (Uvasorb HEB)   3-(4′-methyl benzylidene)-D,L-camphor (Neo Heliopan®MBC)   3-benzylidene camphor   salicylic acid-2-ethylhexyl ester (Neo Heliopan®OS)   4-dimethylaminobenzoic acid-2-ethylhexyl ester (Padimate O)   hydroxy-4-methoxybenzophenone-5-sulfonic acid and Na salt   2,2′-methylene bis-(6-(2H-benzotriazol-2-yl)-4-1,1,3,3-tetramethylbutyl)phenol) (Tinosorb® M)   phenylene bis-benzimidazyl tetrasulfonic acid disodium salt (Neo Heliopan®AP)   2,4-bis-[{(4-(2-ethylhexyloxy)-2-hydroxy}phenyl]-6-(4-methoxyphenyl)-1,3,5-triazine(Tinosorb® S)   benzylidene malonate polysiloxane (Parsol®SLX)   menthyl anthranilate (Neo Heliopan® MA)   2-(4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester (Uvinul® A Plus)   indanylidene compounds in accordance with DE 100 55 940 (=WO 02/38537).   

     Advantageous primary and also secondary sun protection factors are mentioned in WO 2005 123101 A1. Advantageously, these preparations contain at least one UVA filter and/or at least one UVB filter and/or at least one inorganic pigment. The preparations may be present here in various forms such as are conventionally used for sun protection preparations. Thus, they may be in form of a solution, an emulsion of the water-in-oil type (W/O) or of the oil-in-water type (O/W) or a multiple emulsion, for example of the water-in-oil-in-water type (W/O/W), a gel, a hydrodispersion, a solid stick or else an aerosol. 
     In a further preferred embodiment a formulation according to the invention contains a total amount of sunscreen agents, i.e. in particular UV filters and/or inorganic pigments (UV filtering pigments) so that the formulation according to the invention has a light protection factor of greater than or equal to 2 (preferably greater than or equal to 5). Such formulations according to the invention are particularly suitable for protecting the skin and hair. 
     Secondary Sun Protection Factors 
     Besides the groups of primary sun protection factors mentioned above, secondary sun protection factors of the antioxidant type may also be used. Secondary sun protection factors of the antioxidant type interrupt the photochemical reaction chain which is initiated when UV rays penetrate into the skin. Typical examples are amino acids (for example glycine, histidine, tyrosine, tryptophane) and derivatives thereof, imidazoles (for example urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (for example anserine), carotinoids, carotenes (for example alpha-carotene, beta-carotene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, liponic acid and derivatives thereof (for example dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (for example thioredoxine, glutathione, cysteine, cystine, cystamine and glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, alpha-linoleyl, cholesteryl and glyceryl esters thereof) and their salts, dilaurylthiodipropionate, distearylthiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (for example butionine sulfoximines, homocysteine sulfoximine, butionine sulfones, penta-, hexa- and hepta-thionine sulfoximine) in very small compatible dosages, also (metal) chelators (for example alpha-hydroxyfatty acids, palmitic acid, phytic acid, lactoferrine), alpha-hydroxy acids (for example citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof (for example linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives thereof (for example ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (for example vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin resin, rutinic acid and derivatives thereof, glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butyl hydroxytoluene, butyl hydroxyanisole, nordihydroguaiac resin acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, superoxide dismutase, titanium dioxide (for example dispersions in ethanol), zinc and derivatives thereof (for example ZnO, ZnSO 4 ), selenium and derivatives thereof (for example selenium methionine), stilbenes and derivatives thereof (for example stilbene oxide, transstilbene oxide) and derivatives of these active substances suitable for the purposes of the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids). 
     Advantageous inorganic secondary light protection pigments are finely dispersed metal oxides and metal salts which are also mentioned in WO 2005 123101 A1. The total quantity of inorganic pigments, in particular hydrophobic inorganic micro-pigments in the finished cosmetic preparation according to the present invention is advantageously from 0.1 to 30% by weight, preferably 0.5 to 10.0% by weight, in each case based on the total weight of the preparation. 
     Also preferred are particulate UV filters or inorganic pigments, which can optionally be hydrophobed, can be used, such as the oxides of titanium (TiO 2 ), zinc (ZnO), iron (Fe 2 O 3 ), zirconium (ZrO 2 ), silicon (SiO 2 ), manganese (e.g. MnO), aluminium (Al 2 O 3 ), cerium (e.g. Ce 2 O 3 ) and/or mixtures thereof. 
     Actives Modulating Skin and/or Hair Pigmentation 
     Active ingredients. Preferred active ingredients for skin and/or hair lightening are selected from the group consisting of: kojic acid (5-hydroxy-2-hydroxymethyl-4-pyranone), kojic acid derivatives, preferably kojic acid dipalmitate, arbutin, ascorbic acid, ascorbic acid derivatives, preferably magnesium ascorbyl phosphate, hydroquinone, hydroquinone derivatives, resorcinol, resorcinol derivatives, preferably 4-alkylresorcinols and 4-(1-phenylethyl)1,3-dihydroxybenzene (phenylethyl resorcinol), cyclohexylcarbamates (preferably one or more cyclohexyl carbamates disclosed in WO 2010/122178 and WO 2010/097480), sulfur-containing molecules, preferably glutathione or cysteine, alpha-hydroxy acids (preferably citric acid, lactic acid, malic acid), salts and esters thereof, N-acetyl tyrosine and derivatives, undecenoyl phenylalanine, gluconic acid, chromone derivatives, preferably aloesin, flavonoids, 1-aminoethyl phosphinic acid, thiourea derivatives, ellagic acid, nicotinamide (niacinamide), zinc salts, preferably zinc chloride or zinc gluconate, thujaplicin and derivatives, triterpenes, preferably maslinic acid, sterols, preferably ergosterol, benzofuranones, preferably senkyunolide, vinyl guiacol, ethyl guiacol, dionic acids, preferably octodecene dionic acid and/or azelaic acid, inhibitors of nitrogen oxide synthesis, preferably L-nitroarginine and derivatives thereof, 2,7-dinitroindazole or thiocitrulline, metal chelators (preferably alpha-hydroxy fatty acids, phytic acid, humic acid, bile acid, bile extracts, EDTA, EGTA and derivatives thereof), retinoids, soy milk and extract, serine protease inhibitors or lipoic acid or other synthetic or natural active ingredients for skin and hair lightening, the latter preferably used in the form of an extract from plants, preferably bearberry extract, rice extract, papaya extract, turmeric extract, mulberry extract, bengkoang extract, nutgrass extract, liquorice root extract or constituents concentrated or isolated therefrom, preferably glabridin or licochalcone A, artocarpus extract, extract of rumex and ramulus species, extracts of pine species (pinus), extracts of vitis species or stilbene derivatives isolated or concentrated therefrom, saxifrage extract, scutelleria extract, grape extract and/or microalgae extract, in particular Tetraselmis suecica Extract . 
     Skin lighteners. Preferred skin lighteners as component (b) are kojic acid and phenylethyl resorcinol as tyrosinase inhibitors, beta- and alpha-arbutin, hydroquinone, nicotinamide, dioic acid, Mg ascorbyl phosphate and vitamin C and its derivatives, mulberry extract, Bengkoang extract, papaya extract, turmeric extract, nutgrass extract, licorice extract (containing glycyrrhizin), alpha-hydroxy-acids, 4-alkylresorcinols, 4-hydroxyanisole. These skin lighteners are preferred due to their very good activity, in particular in combination with sclareolide according to the present invention. In addition, said preferred skin lighteners are readily available. 
     Tanning agents. Advantageous skin and hair tanning active ingredients in this respect are substrates or substrate analogues of tyrosinase such as L-tyrosine, N-acetyl tyrosine, L-DOPA or L-dihydroxyphenylalanine, xanthine alkaloids such as caffeine, theobromine and theophyl-line and derivatives thereof, proopiomelanocortin peptides such as ACTH, alpha-MSH, peptide analogues thereof and other substances which bind to the melanocortin receptor, peptides such as Val-Gly-Val-Ala-Pro-Gly, Lys-IIe- Gly-Arg-Lys or Leu-Ile-Gly-Lys, purines, pyrimidines, folic acid, copper salts such as copper gluconate, chloride or pyrrolidonate, 1,3,4-oxadiazole-2-thiols such as 5-pyrazin-2-yl-1,3,4-oxadiazole-2-thiol, curcumin, zinc diglycinate (Zn(Gly)2), manganese(II) bicarbonate complexes (“pseudocat-alases”) as described for example in EP 0 584 178, tetrasubstituted cyclohexene deriva-tives as described for example in WO 2005/032501 , isoprenoids as described in WO 2005/102252 and in WO 2006/010661 , melanin derivatives such as Melasyn-100 and MelanZe, diacyl glycerols, aliphatic or cyclic diols, psoralens, prostaglandins and ana-logues thereof, activators of adenylate cyclase and compounds which activate the transfer of melanosomes to keratinocytes such as serine proteases or agonists of the PAR-2 receptor, extracts of plants and plant parts of the chrysanthemum species, san-guisorba species, walnut extracts, urucum extracts, rhubarb extracts, microalgae extracts, in particular Isochrysis galbana, trehalose, erythru-lose and dihydroxyacetone. Flavonoids which bring about skin and hair tinting or brown-ing (e.g. quercetin, rhamnetin, kaempferol, fisetin, genistein, daidzein, chrysin and api-genin, epicatechin, diosmin and diosmetin, morin, quercitrin, naringenin, hesperidin, phloridzin and phloretin) can also be used. 
     The amount of the aforementioned examples of additional active ingredients for the modulation of skin and hair pigmentation (one or more compounds) in the products according to the invention is then preferably 0.00001 to 30 wt. %, preferably 0.0001 to 20 wt. %, particularly preferably 0.001 to 5 wt. %, based on the total weight of the preparation. 
     Anti-Ageing Actives 
     In the context of the invention, anti-ageing or biogenic agents are, for example antioxidants, matrix-metalloproteinase inhibitors (MMPI), skin moisturizing agents, glycosaminglycan stimulators, anti-inflammatory agents, TRPV1 antagonists and plant extracts. 
     Antioxidants. amino acids (preferably glycine, histidine, tyrosine, tryptophane) and derivatives thereof, imidazoles (preferably urocanic acid) and derivatives thereof, peptides, preferably D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (preferably anserine), carnitine, creatine, matrikine peptides (preferably lysyl-threonyl-threonyl-lysyl-serine) and palmitoylated pentapeptides, carotenoids, carotenes (preferably alpha-carotene, betacarotene, lycopene) and derivatives thereof, lipoic acid and derivatives thereof (preferably dihydrolipoic acid), aurothioglucose, propyl thiouracil and other thiols (preferably thioredoxins, glutathione, cysteine, cystine, cystamine and glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, gamma-linoleyl, cholesteryl, glyceryl and oligoglyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (preferably esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (preferably buthionine sulfoximines, homocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very small tolerated doses (e.g. pmol to μmol/kg), also (metal) chelators (preferably alphahydroxy fatty acids, pal mitic acid, phytic acid, lactoferrin, alpha-hydroxy acids (preferably citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, tannins, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof), unsaturated fatty acids and derivatives thereof (preferably gamma-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and derivatives thereof, ubiquinol and derivatives thereof, vitamin C and derivatives (preferably ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate, ascorbyl glucoside), tocopherols and derivatives (preferably vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoic resin, rutinic acid and derivatives thereof, flavonoids and glycosylated precursors thereof, in particular quercetin and derivatives thereof, preferably alpha-glucosyl rutin, rosmarinic acid, carnosol, carnosolic acid, resveratrol, caffeic acid and derivatives thereof, sinapic acid and derivatives thereof, ferulic acid and derivatives thereof, curcuminoids, chlorogenic acid and derivatives thereof, retinoids, preferably retinyl palmitate, retinol or tretinoin, ursolic acid, levulinic acid, butyl hydroxytoluene, butyl hydroxyanisole, nordihydroguaiac acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (preferably ZnO, ZnSO 4 ), selenium and derivatives thereof (preferably selenium methionine), superoxide dismutase, stilbenes and derivatives thereof (preferably stilbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these cited active ingredients which are suitable according to the invention or extracts or fractions of plants having an antioxidant effect, preferably green tea, rooibos, honeybush, grape, rosemary, sage, melissa, thyme, lavender, olive, oats, cocoa, ginkgo, ginseng, liquorice, honeysuckle, sophora, pueraria, pinus, citrus, Phyllanthus emblica or St. John&#39;s wort, grape seeds, wheat germ, Phyllanthus emblica, coenzymes, preferably coenzyme Q10, plastoquinone and menaquinone. Preferred antioxidants are selected from the group consisting of vitamin A and derivatives, vitamin C and derivatives, tocopherol and derivatives, preferably tocopheryl acetate, and ubiquinone. 
     Matrix-Metalloproteinase inhibitors (MMPI). Preferred compositions comprise matrix-metalloproteinase inhibitors, especially those inhibiting matrix-metalloproteinases enzymatically cleaving collagen, selected from the group consisting of: ursolic acid, retinyl palmitate, propyl gallate, precocenes, 6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran, 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran, benzamidine hydrochloride, the cysteine proteinase inhibitors N-ethylmalemide and epsilon-amino-n-caproic acid of the serinprotease inhibitors: phenylmethylsufonylfluoride, collhibin (company Pentapharm; INCI: hydrolysed rice protein), oenotherol (company Soliance; INCI: propylene glycol, aqua, Oenothera biennis root extract, ellagic acid and ellagitannins, for example from pomegranate), phosphoramidone hinokitiol, EDTA, galardin, EquiStat (company Collaborative Group; apple fruit extract, soya seed extract, ursolic acid, soya isoflavones and soya proteins), sage extracts, MDI (company Atrium; INCI: glycosaminoglycans), fermiskin (company Silab/Mawi; INCI: water and lentinus edodes extract), actimp 1.9.3 (company Expanscience/Rahn; INCI: hydrolysed lupine protein), lipobelle soyaglycone (company Mibelle; INCI: alcohol, polysorbate 80, lecithin and soy isoflavones), extracts from green and black tea and further plant extracts, which are listed in WO 02 069992 A1 (see tables 1-12 there, incorporated herein by reference), proteins or glycoproteins from soya, hydrolysed proteins from rice, pea or lupine, plant extracts which inhibit MMPs, preferably extracts from shitake mushrooms, extracts from the leaves of the Rosaceae family, sub-family Rosoideae, quite particularly extracts of blackberry leaf (preferably as described in WO 2005 123101 A1, incorporated herein by reference) as e.g. SymMatrix (company Symrise, INCI: Maltodextrin, Rubus Fruticosus (Blackberry) Leaf Extract). Preferred actives of are selected from the group consisting of retinyl palmitate, ursolic acid, extracts from the leaves of the Rosaceae family, sub-family Rosoideae, genistein and daidzein. 
     Skin-moisturizing agents. Preferred skin moisturizing agents are selected from the group consisting of alkane diols or alkane triols comprising 3 to 12 carbon atoms, preferably C 3 -C 10 -alkane diols and C 3 -C 10 -alkane triols. More preferably the skin moisturizing agents are selected from the group consisting of: glycerol, 1,2-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol and 1,2-decanediol. 
     Glycosaminoglycan stimulators. Preferred compositions comprise substances stimulating the synthesis of glycosaminoglycans selected from the group consisting of hyaluronic acid and derivatives or salts, Subliskin (Sederma, INCI: Sinorhizobium Meliloti Ferment Filtrate, Cetyl Hydroxyethylcellulose, Lecithin), Hyalufix (BASF, INCI: Water, Butylene Glycol, Alpinia galanga leaf extract, Xanthan Gum, Caprylic/Capric Triglyceride), Stimulhyal (Soliance, INCI: Calcium ketogluconate), Syn-Glycan (DSM, INCI: Tetradecyl Aminobutyroylvalylaminobutyric Urea Trifluoroacetate, Glycerin, Magnesium chloride), Kalpariane (Biotech Marine), DC Upregulex (Distinctive Cosmetic Ingredients, INCI: Water, Butylene Glycol, Phospholipids, Hydrolyzed Sericin), glucosamine, N-acetyl glucosamine, retinoids, preferably retinol and vitamin A, Arctium lappa fruit extract, Eriobotrya japonica extract, Genkwanin, N-Methyl-L-serine, (-)-alpha-bisabolol or synthetic alpha-bisabolol such as e.g. Dragosantol and Dragosantol 100 from Symrise, oat glucan, Echinacea purpurea extract and soy protein hydrolysate. Preferred actives are selected from the group consisting of hyaluronic acid and derivatives or salts, retinol and derivatives, (-)-alpha-bisabolol or synthetic alpha-bisabolol such as e.g. Dragosantol and Dragosantol 100 from Symrise, oat glucan, Echinacea purpurea extract, Sinorhizobium Meliloti Ferment Filtrate, Calcium ketogluconate, Alpinia galanga leaf extract and tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate. 
     Anti-inflammatory agents. The compositions may also contain anti-inflammatory and/or redness and/or itch ameliorating ingredients, in particular steroidal substances of the corticosteroid type selected from the group consisting of hydrocortisone, dexamethasone, dexamethasone phosphate, methyl prednisolone or cortisone, are advantageously used as anti-inflammatory active ingredients or active ingredients to relieve reddening and itching, the list of which can be extended by the addition of other steroidal anti-inflammatories. Non-steroidal anti-inflammatories can also be used. Examples which can be cited here are oxicams such as piroxicam or tenoxicam; salicylates such as aspirin, disalcid, solprin or fendosal; acetic acid derivatives such as diclofenac, fenclofenac, indomethacin, sulindac, tolmetin or clindanac; fenamates such as mefenamic, meclofenamic, flufenamic or niflumic; propionic acid derivatives such as ibuprofen, naproxen, benoxaprofen or pyrazoles such as phenylbutazone, oxyphenylbutazone, febrazone or azapropazone. Anthranilic acid derivatives, in particular avenanthramides described in WO 2004 047833 A1, are preferred anti-itch ingredients in a composition according to the present invention. 
     Also useful are natural or naturally occurring anti-inflammatory mixtures of substances or mixtures of substances that alleviate reddening and/or itching, in particular extracts or fractions from camomile, Aloe vera, Commiphora species, Rubia species, willow, willow-herb, oats, calendula, arnica, St John&#39;s wort, honeysuckle, rosemary, Passiflora incarnata, witch hazel, ginger or Echinacea; preferably selected from the group consisting of extracts or fractions from camomile, Aloe vera, oats, calendula, arnica, honeysuckle, rosemary, witch hazel, ginger or Echinacea, and/or pure substances, preferably alpha-bisabolol, apigenin, apigenin-7-glucoside, gingerols, shogaols, gingerdiols, dehydrogingerdiones, paradols, natural or naturally occuring avenanthramides, preferably tranilast, avenanthramide A, avenanthramide B, avenanthramide C, non-natural or non-naturally occuring avenanthramides, preferably dihydroavenanthramide D, dihydroavenanthramide E, avenanthramide D, avenan-thramide E, avenanthramide F, boswellic acid, phytosterols, glycyrrhizin, glabridin and licochalcone A; preferably selected from the group consisting of alpha-bisabolol, natural avenanthramides, non-natural avenanthramides, preferably dihydroavenanthramide D (as described in WO 2004 047833 Al), boswellic acid, phytosterols, glycyrrhizin, and licochalcone A, and/or allantoin, panthenol, lanolin, (pseudo-)ceramides [preferably Ceramide 2, hydroxypropyl bispalmitamide MEA, cetyloxypropyl glyceryl methoxypropyl myristamide, N-(1-hexadecanoyl)-4-hydroxy-L-proline (1-hexadecyl) ester, hydroxyethyl palmityl oxyhydroxypropyl palmitamide], glycosphingolipids, phytosterols, chitosan, mannose, lactose and β-glucans, in particular 1,3-1,4-β-glucan from oats. 
     TRPV1 antagonists. Suitable compounds which reduce the hypersensitivity of skin nerves based on their action as TRPV1 antagonists, encompass e.g. trans-4-tert-butyl cyclo-hexanol as described in WO 2009 087242 A1, or indirect modulators of TRPV1 by an activation of the μ-receptor, e.g. acetyl tetrapeptide-15, are preferred. 
     Anti-cellulite agents. Anti-cellulite agents and lipolytic agents are preferably selected from the group consisting of those described in WO 2007/077541, and beta-adrenergic receptor agonists such as synephrine and its derivatives, and cyclohexyl carbamates described in WO 2010/097479. Agents enhancing or boosting the activity of anti-cellulite agents, in particular agents which stimulate and/or depolarise C nerve fibres, are preferably selected from the group consisting of capsaicin and derivatives thereof, vanillyl-nonylamid and derivatives thereof, L-carnitine, coenzym A, isoflavonoides, soy extracts, ananas extract and conjugated linoleic acid. 
     Fat enhancing agents. Formulations and products according to the present invention may also comprise one or more fat enhancing and/or adipogenic agents as well as agents enhancing or boosting the activity of fat enhancing agents. A fat enhancing agent is for example hydroxymethoxyphenyl propylmethylmethoxybenzofuran (trade name: Sym3D®). 
     Hair Growth Activators or Inhibitors 
     Formulations and products according to the present invention may also comprise one or more hair growth activators, i.e. agents to stimulate hair growth. Hair growth activators are preferably selected from the group consisting of pyrimidine derivatives such as 2,4-diaminopyrimidine-3-oxide (Aminexil), 2,4-diamino-6-piperidinopyrimidine-3-oxide (Minoxidil) and derivatives thereof, 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine and its derivatives, xanthine alkaloids such as caffeine, theobromine and theophylline and derivatives thereof, quercetin and derivatives, dihydroquercetin (taxifolin) and derivatives, potassium channel openers, antiandrogenic agents, synthetic or natural 5-reductase inhibitors, nicotinic acid esters such as tocopheryl nicotinate, benzyl nicotinate and C1-C6 alkyl nicotinate, proteins such as for example the tripeptide Lys-Pro-Val, diphencypren, hormons, finasteride, dutasteride, flutamide, bicalutamide, pregnane derivatives, progesterone and its derivatives, cyproterone acetate, spironolactone and other diuretics, calcineurin inhibitors such as FK506 (Tacrolimus, Fujimycin) and its derivatives, Cyclosporin A and derivatives thereof, zinc and zinc salts, polyphenols, procyanidins, proanthocyanidins, phytosterols such as for example betasitosterol, biotin, eugenol, (±)-beta-citronellol, panthenol, glycogen for example from mussels, extracts from microorganisms, algae, plants and plant parts of for example the genera dandelion (Leontodon or Taraxacum), Orthosiphon, Vitex, Coffea, Paullinia, Theobroma, Asiasarum, Cucurbita or Styphnolobium, Serenoa repens (saw palmetto), Sophora flavescens, Pygeum africanum, Panicum miliaceum, Cimicifuga racemosa, Glycine max, Eugenia caryophyllata, Cotinus coggygria, Hibiscus rosa-sinensis, Camellia sinensis, Ilex paraguariensis, Isochrysis galbana, licorice, grape, apple, barley or hops or/and hydrolysates from rice or wheat. 
     Alternatively, formulations and products according to the present invention may comprise one or more hair growth inhibitors (as described above), i.e. agents to reduce or prevent hair growth. Hair growth inhibitors are preferably selected from the group consisting of activin, activin derivatives or activin agonists, ornithine decarboxylase inhibitors such as alphadifluoromethylornithine or pentacyclic triterpenes like for example ursolic acid, betulin, betulinic acid, oleanolic acid and derivatives thereof, 5alpha-reductase inhibitors, androgen receptor antagonists, S-adenosylmethionine decarboxylase inhibitors, gamma-glutamyl transpeptidase inhibitors, transglutaminase inhibitors, soybean-derived serine protease inhibitors, extracts from microorganisms, algae, different microalgae or plants and plant parts of for example the families Leguminosae, Solanaceae, Graminae, Asclepiadaceae or Cucurbitaceae, the genera Chondrus, Gloiopeltis, Ceramium, Durvillea, Glycine max, Sanguisorba officinalis, Calendula officinalis, Hamamelis virginiana, Arnica montana, Salix alba, Hypericum perforatum or Gymnema sylvestre. 
     Cooling Agents 
     The compositions may also contain one or more substances with a physiological cooling effect (cooling agents), which are preferably selected here from the following list: menthol and menthol derivatives (for example L-menthol, D-menthol, racemic menthol, isomenthol, neoisomenthol, neomenthol) menthylethers (for example (I-menthoxy)-1,2-propandiol, (1-menthoxy)-2-methyl-1,2-propandiol, 1-menthyl-methylether), menthylesters (for example menthylformiate, menthylacetate, menthylisobutyrate, menthyllactates, L-menthyl-L-lactate, L-menthyl-D-lactate, menthyl-(2-methoxy)acetate, menthyl-(2-methoxyethoxy)acetate, menthylpyroglutamate), menthylcarbonates (for example menthylpropyleneglycolcarbonate, menthylethyleneglycolcarbonate, menthylglycerolcarbonate or mixtures thereof), the semi-esters of menthols with a dicarboxylic acid or derivatives thereof (for example monomenthylsuccinate, mono-menthylglutarate, mono-menthylmalonate, O-menthyl succinic acid ester-N,N-(dimethyl)amide, O-menthyl succinic acid ester amide), menthanecarboxylic acid amides (in this case preferably menthanecarboxylic acid-N-ethylamide [WS3] or N α -(men-thanecarbonyl)glycinethylester [WS5], as described in U.S. Pat. No. 4,150,052, menthanecarboxylic acid-N-(4-cyanophenyl)amide or menthanecarboxylic acid-N-(4-cyanomethylphenyl)amide as described in WO 2005 049553 A1, methanecarboxylic acid-N-(alkoxyalkyl)amides), menthone and menthone derivatives (for example L-menthone glycerol ketal), 2,3-dimethyl-2-(2-pro-pyl)-butyric acid derivatives (for example 2,3-dimethyl-2-(2-propyl)-butyric acid-N-methylamide [W523]), isopulegol or its esters (I-(-)-isopulegol, I-(-)-isopulegolacetate), menthane derivatives (for example p-menthane-3,8-diol), cubebol or synthetic or natural mixtures, containing cubebol, pyrrolidone derivatives of cycloalkyldione derivatives (for example 3-methyl-2(1-pyrrolidinyl)-2-cyclopentene-1-one) or tetrahydropyrimidine-2-one (for example iciline or related compounds, as described in WO 2004/026840), further carboxamides (for example N-(2-(pyridin-2-yl)ethyl)-3-p-menthanecarboxamide or related compounds), (1R,25,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-isopropyl)cyclohexane-carboxamide [WS12], oxamates (preferably those described in EP 2033688 A2). 
     Anti-Microbial Agents 
     Suitable anti-microbial agents are, in principle, all substances effective against Grampositive bacteria, such as, for example, 4-Hydroxyacetophenone (SymSave® H) 4-hydroxybenzoic acid and its salts and esters, N-(4-chlorophenyl)-N′-(3,4-dichlorophenyl)urea, 2,4,4′-trichloro-2′-hydroxy-diphenyl ether (triclosan), 4-chloro-3,5-dimethyl-phenol, 2,2′-methylenebis(6-bromo-4-chlorophenol), 3-methyl-4-(1-methylethyl)phenol, 2-benzyl-4-chloro-phenol, 3-(4-chlorophenoxy)-1,2-propanediol, 3-iodo-2-propynyl butylcarbamate, chlorhexidine, 3,4,4′-trichlorocarbanilide (TTC), antibacterial fragrances, thymol, thyme oil, eugenol, oil of cloves, menthol, mint oil, farnesol, phenoxyethanol, glycerol monocaprate, glycerol monocaprylate, glycerol monolaurate (GML), diglycerol monocaprate (DMC), salicylic acid N-alkylamides, such as, for example, n-octylsalicylamide or n-decylsalicylamide. 
     Enzyme Inhibitors 
     Suitable enzyme inhibitors are, for example, esterase inhibitors. These are preferably trialkyl citrates, such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and, in particular, triethyl citrate (Hydagen CAT). The substances inhibit enzyme activity, thereby reducing the formation of odour. Other substances which are suitable esterase inhibitors are sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesterol, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and esters thereof, such as, for example, glutaric acid, monoethyl glutarate, diethyl glutarate, adipic acid, monoethyl adipate, diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and esters thereof, such as, for example, citric acid, malic acid, tartaric acid or diethyl tartrate, and zinc glycinate. 
     Odour Absorbers and Antiperspirant Active Agents 
     Suitable odour absorbers are substances which are able to absorb and largely retain odour-forming compounds. They lower the partial pressure of the individual components, thus also reducing their rate of diffusion. It is important that perfumes must remain unimpaired in this process. Odour absorbers are not effective against bacteria. They comprise, for example, as main constituent, a complex zinc salt of ricinoleic acid or specific, largely odourneutral fragrances which are known to the person skilled in the art as “fixatives”, such as, for example, extracts of labdanum or styrax or certain abietic acid derivatives. The odour masking agents are fragrances or perfume oils, which, in addition to their function as odour masking agents, give the deodorants their respective fragrance note. Perfume oils which may be mentioned are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts from flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches, and resins and balsams. Also suitable are animal products, such as, for example, civet and castoreum. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol, and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexylpropionate, styrallyl propionate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether, and the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones include, for example, the ionones and methyl cedryl ketone, the alcohols include anethole, citronellol, eugenol, isoeugenol, geraniol, linaool, phenylethyl alcohol and terpineol, and the hydrocarbons include mainly the terpenes and balsams. Preference is, however, given to using mixtures of different fragrances which together produce a pleasing fragrance note. Essential oils of relatively low volatility, which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, camomile oil, oil of cloves, melissa oil, mint oil, cinnamon leaf oil, linden flower oil, juniperberry oil, vetiver oil, olibanum oil, galbanum oil, labdanum oil and lavandin oil. Preference is given to using bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, a-hexylcinnamaldehyde, geraniol, benzylacetone, cyclamen aldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, lemon oil, mandarin oil, orange oil, allyl amyl glycolate, cyclovertal, lavandin oil, clary sage oil, β-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix coeur, iso-E-super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilat, irotyl and floramat alone or in mixtures. 
     Suitable astringent antiperspirant active ingredients are primarily salts of aluminium, zirconium or of zinc. Such suitable antihydrotic active ingredients are, for example, aluminium chloride, aluminium chlorohydrate, aluminium dichlorohydrate, aluminium sesquichlorohydrate and complex compounds thereof, e.g. with 1,2-propylene glycol, aluminium hydroxyallantoinate, aluminium chloride tartrate, aluminium zirconium trichlorohydrate, aluminium zirconium tetrachlorohydrate, aluminium zirconium pentachlorohydrate and complex compounds thereof, e.g. with amino acids, such as glycine. 
     Film Formers and Anti-Dandruff Agents 
     Standard film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid and salts thereof and similar compounds. 
     Suitable antidandruff agents are Pirocton Olamin (1-hydroxy-4-methyl-6-(2,4,4-trime-thylpentyl)-2-(1H)-pyridinone monoethanolamine salt), Baypival® (Climbazole), Ketoconazol® (4-acetyl-1-{4-[2-(2,4-dichlorophenyl) r-2-(1H-imidazol-1-ylmethyl)-1,3-dioxylan-c-4-ylmeth-oxyphenyl}-piperazine, ketoconazole, elubiol, selenium disulfide, colloidal sulfur, sulfur polyethylene glycol sorbitan monooleate, sulfur ricinol polyethoxylate, sulfur tar distillate, salicylic acid (or in combination with hexachlorophene), undecylenic acid, monoethanolamide sulfosuccinate Na salt, Lamepon® UD (protein/undecylenic acid condensate), zinc pyrithione, aluminium pyrithione and magnesium pyrithione/dipyrithione magnesium sulfate. 
     Carriers and Hydrotropes 
     Preferred cosmetics carrier materials are solid or liquid at 25° C. and 1013 mbar (including highly viscous substances) as for example glycerol, 1,2-propylene glycol, 1,2-butylene glycol, 1,3-propylene glycol, 1,3-butylene glycol, ethanol, water and mixtures of two or more of said liquid carrier materials with water. Optionally, these preparations according to the invention may be produced using preservatives or solubilizers. Other preferred liquid carrier substances, which may be a component of a preparation according to the invention are selected from the group consisting of oils such as vegetable oil, neutral oil and mineral oil. 
     Preferred solid carrier materials, which may be a component of a preparation according to the invention are hydrocolloids, such as starches, degraded starches, chemically or physically modified starches, dextrins, (powdery) maltodextrins (preferably with a dextrose equivalent value of 5 to 25, preferably of 10-20), lactose, silicon dioxide, glucose, modified celluloses, gum arabic, ghatti gum, traganth, karaya, carrageenan, pullulan, curdlan, xanthan gum, gellan gum, guar flour, carob bean flour, alginates, agar, pectin and inulin and mixtures of two or more of these solids, in particular maltodextrins (preferably with a dextrose equivalent value of 15-20), lactose, silicon dioxide and/or glucose. 
     In addition, hydrotropes, for example ethanol, isopropyl alcohol or polyols, may be used to improve flow behaviour. Suitable polyols preferably contain 2 to 15 carbon atoms and at least two hydroxyl groups. The polyols may contain other functional groups, more especially amino groups, or may be modified with nitrogen. Typical examples are
     glycerol;   alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1000 Dalton;   technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10, such as for example technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight;   methylol compounds such as, in particular, trimethylol ethane, trimethylol propane, trimethylol butane, pentaerythritol and dipentaerythritol;   lower alkyl glucosides, particularly those containing 1 to 8 carbon atoms in the alkyl group, for example methyl and butyl glucoside;   sugar alcohols containing 5 to 12 carbon atoms, for example sorbitol or mannitol,   sugars containing 5 to 12 carbon atoms, for example glucose or sucrose;   amino sugars, for example glucamine;   dialcoholamines, such as diethanolamine or 2-aminopropane-1,3-diol.   

     Preservatives 
     Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of compounds listed in Appendix 6, Parts A and B of the Kosmetikverordnung (“Cosmetics Directive”). 
     Perfume Oils and Fragrances 
     Suitable perfume oils are mixtures of natural and synthetic perfumes. Natural perfumes include the extracts of blossoms (lily, lavender, rose, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, orange), roots (nutmeg, angelica, celery, cardamom, costus, iris, calmus), woods (pinewood, sandalwood, guaiac wood, cedarwood, rosewood), herbs and grasses (tarragon, lemon grass, sage, thyme), needles and branches (spruce, fir, pine, dwarf pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax). Animal raw materials, for example civet and beaver, may also be used. Typical synthetic perfume compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Examples of perfume compounds of the ester type are benzyl acetate, phenoxyethyl isobutyrate, p-tert.butyl cyclohexylacetate, linalyl acetate, dimethyl benzyl carbinyl acetate, phenyl ethyl acetate, linalyl benzoate, benzyl formate, ethylmethyl phenyl glycinate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate. Ethers include, for example, benzyl ethyl ether while aldehydes include, for example, the linear alkanals containing 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal. Examples of suitable ketones are the ionones, □?-isomethylionone and methyl cedryl ketone. Suitable alcohols are anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol. The hydrocarbons mainly include the terpenes and balsams. However, it is preferred to use mixtures of different perfume compounds which, together, produce an agreeable perfume. Other suitable perfume oils are essential oils of relatively low volatility which are mostly used as aroma components. Examples are sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, lime-blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil, ladanum oil and lavendin oil. The following are preferably used either individually or in the form of mixtures: bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, sandelice, citrus oil, mandarin oil, orange oil, allylamyl glycolate, cyclovertal, lavendin oil, clary oil, damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romillat, irotyl and floramat. 
     Dyes 
     Suitable dyes are any of the substances suitable and approved for cosmetic purposes as listed, for example, in the publication “Kosmetische Färbemittel” of the Farbstoffkommission der Deutschen Forschungsgemeinschaft, Verlag Chemie, Weinheim, 1984, pages 81 to 106. Examples include cochineal red A (C.I. 16255), patent blue V (C.I. 42051), indigotin (C.I. 73015), chlorophyllin (C.I. 75810), quinoline yellow (C.I. 47005), titanium dioxide (C.I. 77891), indanthrene blue RS (C.I. 69800) and madder lake (C.I. 58000). Luminol may also be present as a luminescent dye. Advantageous coloured pigments are for example titanium dioxide, mica, iron oxides (e.g. Fe 2 O 3  Fe 3 O 4 , FeO(OH)) and/or tin oxide. Advantageous dyes are for example carmine, Berlin blue, chromium oxide green, ultramarine blue and/or manganese violet. 
     Surfantants and Co-Surfactants 
     Anionic (co-) Surfactants 
     Preferably, surfactants of the sulfonate type, alk(en)yl sulfonates, alkoxylated alk(en)yl sulfates, ester sulfonates and/or soaps are used as the anionic surfactants. Suitable surfactants of the sulfonate type are advantageously C 9-13  alkylbenzene sulfonates, olefin sulfonates, i.e. mixtures of alkene- and hydroxyalkane sulfonates, and disulfonates, as are obtained, for example, by the sulfonation with gaseous sulfur trioxide of C12-18 monoolefins having a terminal or internal double bond and subsequent alkaline or acidic hydrolysis of the sulfonation products. 
     Alk(en)yl sulfates. Preferred alk(en)yl sulfates are the alkali and especially the sodium salts of the sulfuric acid half-esters of the C 12 -C 18  fatty alcohols, for example, from coconut butter alcohol, tallow alcohol, lauryl, myristyl, cetyl or stearyl alcohol or from C 8 -C 20  oxo alcohols and those half-esters of secondary alcohols of these chain lengths. Alk(en)yl sulfates of the cited chain lengths that comprise a synthetic straight chain alkyl group manufactured petrochemically are also preferred. The C 14 -C 16  alkyl sulfates and C 12 -C 15  alkyl sulfates as well as C 14 -C 15  alkyl sulfates and C 14 -C 16  alkyl sulfates are particularly preferred on the grounds of laundry performance. The 2,3-alkyl sulfates, which can be obtained from Shell Oil Company under the trade name DAN™, are also suitable anionic surfactants. 
     Alk(en)yl ether sulfates. Sulfuric acid mono-esters derived from straight-chained or branched C 7 -C 21  alcohols ethoxylated with 1 to 6 moles ethylene oxide are also suitable, such as 2-methyl-branched C 9 -C 11  alcohols with an average of 3.5 mol ethylene oxide (EO) or C 12 -C 18  fatty alcohols with 1 to 4 EO. 
     Ester sulfonates. The esters of alpha-sulfo fatty acids (ester sulfonates), e.g., the alpha-sulfonated methyl esters of hydrogenated coco-, palm nut- or tallow acids are likewise suitable. 
     Soaps. Soaps, in particular, can be considered as further anionic surfactants. Saturated fatty acid soaps are particularly suitable, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, hydrogenated erucic acid and behenic acid, and especially soap mixtures derived from natural fatty acids such as coconut oil fatty acid, palm kernel oil fatty acid or tallow fatty acid. Those soap mixtures are particularly preferred that are composed of 50 to 100 wt. % of saturated C 12 -C 24  fatty acid soaps and 0 to 50 wt. % of oleic acid soap. 
     Ether carboxylic acids. A further class of anionic surfactants is that of the ether carboxylic acids, obtainable by treating fatty alcohol ethoxylates with sodium chloroacetate in the presence of basic catalysts. They have the general formula: RO(CH 2 CH 2 O) p CH 2 COOH with R=C 1 -C 18  and p=0.1 to 20. Ether carboxylic acids are insensitive to water hardness and possess excellent surfactant properties. 
     Nonionic (co-)Surfactants 
     Alkohol alkoxylates. The added nonionic surfactants are preferably alkoxylated and/or propoxylated, particularly primary alcohols having preferably 8 to 18 carbon atoms and an average of 1 to 12 mol ethylene oxide (EO) and/or 1 to 10 mol propylene oxide (PO) per mol alcohol. C 8 -C 16 -Alcohol alkoxylates, advantageously ethoxylated and/or propoxylated C10-C15-alcohol alkoxylates, particularly C 12 -C 14  alcohol alkoxylates, with an ethoxylation degree between 2 and 10, preferably between 3 and 8, and/or a propoxylation degree between 1 and 6, preferably between 1.5 and 5, are particularly preferred. The cited degrees of ethoxylation and propoxylation constitute statistical average values that can be a whole or a fractional number for a specific product. Preferred alcohol ethoxylates and propoxylates have a narrowed homolog distribution (narrow range ethoxylates/propoxylates, NRE/NRP). In addition to these nonionic surfactants, fatty alcohols with more than 12 EO can also be used. Examples of these are (tallow) fatty alcohols with 14 EO, 16 EO, 20 EO, 25 EO, 30 EO or 40 EO. 
     Alkylglycosides (APG®). Furthermore, as additional nonionic surfactants, alkyl glycosides that satisfy the general Formula RO(G)x, can be added, e.g., as compounds, particularly with anionic surfactants, in which R means a primary linear or methyl-branched, particularly 2-methyl-branched, aliphatic group containing 8 to 22, preferably 12 to 18 carbon atoms and G stands for a glycose unit containing 5 or 6 carbon atoms, preferably for glucose. The degree of oligomerization x, which defines the distribution of monoglycosides and oligoglycosides, is any number between 1 and 10, preferably between 1.1 and 1.4. 
     Fatty acid ester alkoxylates. Another class of preferred nonionic surfactants, which are used either as the sole nonionic surfactant or in combination with other nonionic surfactants, in particular, together with alkoxylated fatty alcohols and/or alkyl glycosides, are alkoxylated, preferably ethoxylated or ethoxylated and propoxylated fatty acid alkyl esters preferably containing 1 to 4 carbon atoms in the alkyl chain, more particularly the fatty acid methyl esters which are described, for example, in Japanese Patent Application JP-A-58/217598 or which are preferably produced by the process described in International Patent Application WO-A-90/13533. Methyl esters of C 12 -C 18  fatty acids containing an average of 3 to 15 EO, particularly containing an average of 5 to 12 EO, are particularly preferred. 
     Amine oxides. Nonionic surfactants of the amine oxide type, for example, N-coco alkyl-N,N-dimethylamine oxide and N-tallow alkyl-N,N-dihydroxyethylamine oxide, and the fatty acid alkanolamides may also be suitable. The quantity in which these nonionic surfactants are used is preferably no more than the quantity in which the ethoxylated fatty alcohols are used and, particularly no more than half that quantity. 
     Gemini surfactants. The so-called gemini surfactants can be considered as further surfactants. Generally speaking, such compounds are understood to mean compounds that have two hydrophilic groups and two hydrophobic groups per molecule. As a rule, these groups are separated from one another by a “spacer”. The spacer is usually a hydrocarbon chain that is intended to be long enough such that the hydrophilic groups are a sufficient distance apart to be able to act independently of one another. These types of surfactants are generally characterized by an unusually low critical micelle concentration and the ability to strongly reduce the surface tension of water. In exceptional cases, however, not only dimeric but also trimeric surfactants are meant by the term gemini surfactants. Suitable gemini surfactants are, for example, sulfated hydroxy mixed ethers according to German Patent Application DE 4321022 Al or dimer alcohol bis- and trimer alcohol tris sulfates and ether sulfates according to International Patent Application WO 96/23768 A1. Blocked end group dimeric and trimeric mixed ethers according to German Patent Application DE 19513391 A1 are especially characterized by their bifunctionality and multifunctionality. Gemini polyhydroxyfatty acid amides or polyhydroxyfatty acid amides, such as those described in International Patent Applications WO 95/19953 A1, WO 95/19954 A1 and WO 95/19955 A1 can also be used. 
     Cationic Co-Surfactants 
     Tetraalkyl ammonium salts. Cationically active surfactants comprise the hydrophobic high molecular group required for the surface activity in the cation by dissociation in aqueous solution. A group of important representatives of the cationic surfactants are the tetraalkyl ammonium salts of the general formula: (R 1 R 2 R 3 R 4 N + ) X − . Here R1 stands for C 1 -C 8  alk(en)yl, R 2 , R 3  and R 4 , independently of each other, for alk(en)yl radicals having 1 to 22 carbon atoms. X is a counter ion, preferably selected from the group of the halides, alkyl sulfates and alkyl carbonates. Cationic surfactants, in which the nitrogen group is substituted with two long acyl groups and two short alk(en)yl groups, are particularly preferred. 
     Esterquats. A further class of cationic surfactants particularly useful as co-surfactants for the present invention is represented by the so-called esterquats. Esterquats are generally understood to be quaternised fatty acid triethanolamine ester salts. These are known compounds which can be obtained by the relevant methods of preparative organic chemistry. Reference is made in this connection to International patent application WO 91/01295 Al, according to which triethanolamine is partly esterified with fatty acids in the presence of hypophosphorous acid, air is passed through the reaction mixture and the whole is then quaternised with dimethyl sulphate or ethylene oxide. In addition, German patent DE 4308794 C1 describes a process for the production of solid esterquats in which the quaternisation of triethanolamine esters is carried out in the presence of suitable dispersants, preferably fatty alcohols. 
     Typical examples of esterquats suitable for use in accordance with the invention are products of which the acyl component derives from monocarboxylic acids corresponding to formula RCOOH in which RCO is an acyl group containing 6 to 10 carbon atoms, and the amine component is triethanolamine (TEA). Examples of such monocarboxylic acids are caproic acid, caprylic acid, capric acid and technical mixtures thereof such as, for example, so-called headfractionated fatty acid. Esterquats of which the acyl component derives from monocarboxylic acids containing 8 to 10 carbon atoms, are preferably used. Other esterquats are those of which the acyl component derives from dicarboxylic acids like malonic acid, succinic acid, maleic acid, fumaric acid, glutaric acid, sorbic acid, pimelic acid, azelaic acid, sebacic acid and/or dodecanedioic acid, but preferably adipic acid. Overall, esterquats of which the acyl component derives from mixtures of monocarboxylic acids containing 6 to 22 carbon atoms, and adipic acid are preferably used. The molar ratio of mono and dicarboxylic acids in the final esterquat may be in the range from 1:99 to 99:1 and is preferably in the range from 50:50 to 90:10 and more particularly in the range from 70:30 to 80:20. Besides the quaternised fatty acid triethanolamine ester salts, other suitable esterquats are quaternized ester salts of mono/dicarboxylic acid mixtures with diethanolalkyamines or 1,2-dihydroxypropyl dialkylamines. The esterquats may be obtained both from fatty acids and from the corresponding triglycerides in admixture with the corresponding dicarboxylic acids. One such process, which is intended to be representative of the relevant prior art, is proposed in European patent EP 0750606 B1. To produce the quaternised esters, the mixtures of mono- and dicarboxylic acids and the triethanolamine—based on the available carboxyl functions—may be used in a molar ratio of 1.1:1 to 3:1. With the performance properties of the esterquats in mind, a ratio of 1.2:1 to 2.2:1 and preferably 1.5:1 to 1.9:1 has proved to be particularly advantageous. The preferred esterquats are technical mixtures of mono-, di- and triesters with an average degree of esterification of 1.5 to 1.9. 
     Amphoteric or Zwitterionic Co-Surfactants 
     Betaines. Amphoteric or ampholytic surfactants possess a plurality of functional groups that can ionize in aqueous solution and thereby--depending on the conditions of the medium--lend anionic or cationic character to the compounds (see DIN 53900, July 1972). 
     Close to the isoelectric point (around pH 4), the amphoteric surfactants form inner salts, thus becoming poorly soluble or insoluble in water. Amphoteric surfactants are subdivided into ampholytes and betaines, the latter existing as zwitterions in solution. Ampholytes are amphoteric electrolytes, i.e. compounds that possess both acidic as well as basic hydrophilic groups and therefore behave as acids or as bases depending on the conditions. Especially betaines are known surfactants which are mainly produced by carboxyalkylation, preferably carboxymethylation, of amine compounds. The starting materials are preferably condensed with halocarboxylic acids or salts thereof, more particularly sodium chloroacetate, one mole of salt being formed per mole of betaine. The addition of unsaturated carboxylic acids, such as acrylic acid for example, is also possible. Examples of suitable betaines are the carboxy alkylation products of secondary and, in particular, tertiary amines which correspond to formula R 1 R 2 R 3 N—(CH2) q COOX where R 1  is a an alkyl radical having 6 to 22 carbon atoms, R 2  is hydrogen or an alkyl group containing 1 to 4 carbon atoms, R 3  is an alkyl group containing 1 to 4 carbon atoms, q is a number of 1 to 6 and X is an alkali and/or alkaline earth metal or ammonium. Typical examples are the carboxymethylation products of hexylmethylamine, hexyldimethylamine, octyldimethylamine, decyldimethylamine, C 12/14 -cocoalkyldimethylamine, myristyldimethylamine, cetyldimethylamine, stearyldimethylamine, stearylethylmethylamine, oleyldimethylamine, C 16/18 -tallowalkyldimethylamine and their technical mixtures, and particularly dodecyl methylamine, dodecyl dimethylamine, dodecyl ethyl methylamine and technical mixtures thereof. 
     Alkylamido betaines. Other suitable betaines are the carboxyalkylation products of amidoamines corresponding to formula R 1 CO(R 3 )(R 4 )—NH—(CH 2 ) p —N—(CH 2 ) q COOX in which R 1 CO is an aliphatic acyl radical having 6 to 22 carbon atoms and 0 or 1 to 3 double bonds, R 2  is hydrogen or an alkyl radical having 1 to 4 carbon atoms, R 3  is an alkyl radical having 1 to 4 carbon atoms, p is a number from 1 to 6, q is a number from 1 to 3 and X is an alkali and/or alkaline earth metal or ammonium. Typical examples are reaction products of fatty acids having 6 to 22 carbon atoms, like for example caproic acid, caprylic acid, caprinic acid, lauric acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linolic acid linoleic acid, elaeostearic acid, arachidonic acid, gadoleic acid, behenic acid, erucic acid and their technical mixtures with N,N-dimethylaminoethylamine, N,N-dimethylaminopropylamine, N,N-diethylaminoethylamine and N,N-diethylaminopropylamine, which are condensed with sodium chloroacetate. The commercially available products include Dehyton® K and Dehyton® PK (Cognis Deutschland GmbH &amp; Co., KG) as well as Tego® Betaine (Goldschmidt). 
     Imidazolines. Other suitable starting materials for the betaines to be used for the purposes of the invention are imidazolines. These substances are also known and may be obtained, for example, by cyclizing condensation of 1 or 2 moles of C 6   − C 22  fatty acids with polyfunctional amines, such as for example aminoethyl ethanolamine (AEEA) or diethylenetriamine. The corresponding carboxyalkylation products are mixtures of different open-chain betaines. Typical examples are condensation products of the above-mentioned fatty acids with AEEA, preferably imidazolines based on lauric acid, which are subsequently betainised with sodium chloroacetate. The commercially available products include Dehyton® G (Cognis Deutschland GmbH &amp; Co., KG) 
     The amount of (co-)surfactant comprised in the inventive compositions is advantageously 0.1 wt. % to 90 wt. %, particularly 10 wt. % to 80 wt. % and particularly preferably 20 wt. % to 70 wt.-%. 
     Preparations 
     Preferred compositions according to the present inventions are selected from the group of products for treatment, protecting, care and cleansing of the skin and/or hair or as a make-up product, preferably as a leave-on product (meaning that the one or more compounds of formula (I) stay on the skin and/or hair for a longer period of time, compared to rinse-off products, so that the moisturizing and/or anti-ageing and/or wound healing promoting action thereof is more pronounced). 
     The formulations according to the invention are preferably in the form of an emulsion, e.g. W/O (water-in-oil), 0/W (oil-in-water), W/O/W (water-in-oil-in-water), O/W/O (oil-in-water-in-oil) emulsion, PIT emulsion, Pickering emulsion, emulsion with a low oil content, micro- or nanoemulsion, a solution, e.g. in oil (fatty oils or fatty acid esters, in particular C 6   - C 32  fatty acid C 2 -C 30  esters) or silicone oil, dispersion, suspension, creme, lotion or milk, depending on the production method and ingredients, a gel (including hydrogel, hydrodispersion gel, oleogel), spray (e.g. pump spray or spray with propellant) or a foam or an impregnating solution for cosmetic wipes, a detergent, e.g. soap, synthetic detergent, liquid washing, shower and bath preparation, bath product (capsule, oil, tablet, salt, bath salt, soap, etc.), effervescent preparation, a skin care product such as e.g. an emulsion (as described above), ointment, paste, gel (as described above), oil, balsam, serum, powder (e.g. face powder, body powder), a mask, a pencil, stick, roll-on, pump, aerosol (foaming, non-foaming or post-foaming), a deodorant and/or antiperspirant, mouthwash and mouth rinse, a foot care product (including keratolytic, deodorant), an insect repellent, a sunscreen, aftersun preparation, a shaving product, aftershave balm, pre- and aftershave lotion, a depilatory agent, a hair care product such as e.g. shampoo (including 2-in-1 shampoo, anti-dandruff shampoo, baby shampoo, shampoo for dry scalps, concentrated shampoo), conditioner, hair tonic, hair water, hair rinse, styling creme, pomade, perm and setting lotion, hair spray, styling aid (e.g. gel or wax), hair smoothing agent (detangling agent, relaxer), hair dye such as e.g. temporary direct-dyeing hair dye, semi-permanent hair dye, permanent hair dye, hair conditioner, hair mousse, eye care product, make-up, make-up remover or baby product. 
     The formulations according to the invention are particularly preferably in the form of an emulsion, in particular in the form of a W/O, O/W, W/O/W, O/W/O emulsion, PIT emulsion, Pickering emulsion, emulsion with a low oil content, micro- or nanoemulsion, a gel (including hydrogel, hydrodispersion gel, oleogel), a solution e.g. in oil (fatty oils or fatty acid esters, in particular C 6 -C 32  fatty acid C 2 -C 30  esters)) or silicone oil, or a spray (e.g. pump spray or spray with propellant). 
     Auxiliary substances and additives can be included in quantities of 5 to 99 wt.-percent, preferably 10 to 80 wt.-percent, based on the total weight of the formulation. The amounts of cosmetic or dermatological auxiliary agents and additives and perfume to be used in each case can easily be determined by the person skilled in the art by simple trial and error, depending on the nature of the particular product. 
     The preparations can also contain water in a quantity of up to 99 wt.-percent, preferably 5 to 80 wt.-percent, based on the total weight of the preparation. 
     INDUSTRIAL APPLICATION 
     In a preferred embodiment the compositions according to the present invention comprise the components in the following amounts:
     (a) about 0.01 to about 5 wt.-percent, preferably about 0.05 to about 1 wt.-percent compounds of formula (I);   (b) about 1 to about 70 wt.-percent, preferably about 3 to about 50 wt.-percent and more preferably about 5 to about 40 wt.-percent oil bodies and/or waxes;   (c) 0.1 to about 25 wt.-percent, preferably about 0,2 to about 10 wt.-percent and more preferably about 0,3 to about 5 wt.-percent emulsifiers;   (d) 0 to about 25 wt.-percent, preferably about 0.01 to about 10 wt.-percent and more preferably about 0,05 to about 5 wt.-percent active principles;   

     on condition that the amounts add—optionally together with water and additional ingredients—to 100 wt.-percent 
     The inventive compositions may contain water or are essentially free of water. Essentially free means that the amount of water is less than 2, preferably less than 1 and more preferably less than 0.5 wt.-percent calculated on the final product. 
     The compositions according to the invention may represent o/w or w/o or multiple o/w/o or w/o/w emulsion. They can be used as an intermediate or a final product for example in the form of a lotion, a cream or a stick. 
     Additional embodiments of the invention concern: 
     A first method of stabilizing an emulsion against separation whereby a working amount of at least one compound of formula (I) is added. 
     A second method of reducing the size of water or oil droplets in an emulsion whereby a working amount of at least one compound of formula (I) is added. 
     A third method of improving foam stability of shampoos whereby a working amount of at least one compound of formula (I) is added. 
     A first use of a compound according to formula (I) as stabilizers against separation for compositions, preferably cosmetic compositions, but also encompassing dermatologic or pharmaceutical compositions. 
     A second use of a compound according to formula (I) for reducing the size of water or oil droplets in an emulsion. 
     A third use of a compound according to formula (I) for improving foam stability of shampoos. 
     Compositions 
     Preferred compositions encompass:
     (I) (a) Benzoic acid -3-hydroxypropylester   

     
       
         
         
             
             
         
       
         
         
           
             (b1) at least one, two, three, four or more oil bodies selected from the group consisting of Caprylic Capric Triglycerides, Mineral Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Butyrospermum Parkii (Shea) Butter, Dicaprylyl Ether, Cyclomethicone or Dimethicone, C12-15 Alkyl Benzoate, Isopropyl Pa Imitate or Isopropyl Myristate, Octyldodecanol, Cetearyl Ethylhexanoate or Cetearyl Nonanoate, Ethylhexyl Isononanoate, Propylene Glycol Dicaprylate/Dicaprate, Propylheptyl Caprylate, Decyl Oleate, Hexyl Laurate, Ethylhexyl Stearate, Triisononanoin, Isoadipate, Stearyl Heptanoate and Stearyl Caprylate, and/or 
             (b2) at least one, two, three, for or more emulsifiers selected from the group consisting of PEG-100 Stearate, Cetearyl Glycoside, Distearyldimounium Chloride, Palmitamidopropyltrimonium Chloride, Glyceryl Stearate Citrate or Glyceryl Oleate, Citrate, Polyglyceryl-3 Methylglucose Distearate, Cetearyl Alcohol, Potassium Cetyl Phosphate, Sodium Cetyl Phosphate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer (Polymeric Emulsifier), Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer (Polymeric Emulsifier), Polyglyceryl -4 Caprate or Polyglyceryl-4 Caprylate/Caprate, Cetyl PEG/PPG-10/1, Dimethicone, Polyglyceryl-6 Dioleate, Polyglyceryl-2 Stearate, PEG-30 Dipoly-hydroxystearate Sodium Stearoyl Lactylate and PEG-40 Hydrogenated Castor Oil. 
           
         
         (II) (a) Anisic acid -3-hydroxypropylester 
       
    
     
       
         
         
             
             
         
       
         
         
           
             (b1) at least one, two, three, four or more oil bodies selected from the group consisting of Caprylic Capric Triglycerides, Mineral Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Butyrospermum Parkii (Shea) Butter, Dicaprylyl Ether, Cyclomethicone or Dimethicone, C12-15 Alkyl Benzoate, Isopropyl Pa Imitate or Isopropyl Myristate, Octyldodecanol, Cetearyl Ethylhexanoate or Cetearyl Nonanoate, Ethylhexyl Isononanoate, Propylene Glycol Dicaprylate/Dicaprate, Propylheptyl Caprylate, Decyl Oleate, Hexyl Laurate, Ethylhexyl Stearate, Triisononanoin, Isoadipate, Stearyl Heptanoate and Stearyl Caprylate, and/or 
             (b2) at least one, two, three, for or more emulsifiers selected from the group consisting of PEG-100 Stearate, Cetearyl Glycoside, Distearyldimounium Chloride, Palmitamidopropyltrimonium Chloride, Glyceryl Stearate Citrate or Glyceryl Oleate, Citrate, Polyglyceryl-3 Methylglucose Distearate, Cetearyl Alcohol, Potassium Cetyl Phosphate, Sodium Cetyl Phosphate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer 
           
         
       
    
     (Polymeric Emulsifier), Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer (Polymeric Emulsifier), Polyglyceryl -4 Caprate or Polyglyceryl-4 Caprylate/Caprate, Cetyl PEG/PPG-10/1, Dimethicone, Polyglyceryl-6 Dioleate, Polyglyceryl-2 Stearate, PEG-30 Dipoly-hydroxystearate, Sodium Stearoyl Lactylate and PEG-40 Hydrogenated Castor Oil.
     (III) (a) N-Methylsalicylamid   

     
       
         
         
             
             
         
       
         
         
           
             (b1) at least one, two, three, four or more oil bodies selected from the group consisting of Caprylic Capric Triglycerides, Mineral Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Butyrospermum Parkii (Shea) Butter, Dicaprylyl Ether, Cyclomethicone or Dimethicone, C12-15 Alkyl Benzoate, Isopropyl Palmitate or Isopropyl Myristate, Octyldodecanol, Cetearyl Ethylhexanoate or Cetearyl Nonanoate, Ethylhexyl Isononanoate, Propylene Glycol Dicaprylate/Dicaprate, Propylheptyl Caprylate, Decyl Oleate, Hexyl Laurate, Ethylhexyl Stearate, Triisononanoin, Isoadipate, Stearyl 
             Heptanoate and Stearyl Caprylate, and/or (b2) at least one, two, three, for or more emulsifiers selected from the group consisting of PEG-100 Stearate, Cetearyl Glycoside, Distearyldimounium Chloride, Palmitamidopropyltrimonium Chloride, Glyceryl Stearate Citrate or Glyceryl Oleate, Citrate, Polyglyceryl-3 Methylglucose Distearate, Cetearyl Alcohol, Potassium Cetyl Phosphate, Sodium Cetyl Phosphate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer (Polymeric Emulsifier), Ammonium Acryloyldimethyltaurate/Beheneth-25 Methacrylate Crosspolymer (Polymeric Emulsifier), Polyglyceryl -4 Caprate or Polyglyceryl-4 Caprylate/Caprate, Cetyl PEG/PPG-10/1, Dimethicone, Polyglyceryl-6 Dioleate, Polyglyceryl-2 Stearate, PEG-30 Dipoly-hydroxystearate Sodium Stearoyl Lactylate and PEG-40 Hydrogenated Castor Oil. 
           
         
       
    
     Further Preferred Compositions Encompass:
     (I) (a) Benzoic acid -3-hydroxypropylester   

     
       
         
         
             
             
         
       
         
         
           
             (b1) at least one, two, three, four or more surfactants selected from the group consisting of Sodium Laureth Sulfate, Cocoamidopropyl Betaine, Cocomide MEA, Disodium Cocoyl Glutamate, PEG-7 Glyceryl Cocoate, Sodium Stearoyllactylate, Lauryl Glycoside, Disodium Cocoamphodiacetate, Sodium C14-16 Olefin Sulfonate, Sodium C14-17 Alkyl Sec Sulfonate, and Disodium Laureth Sulfosuccinate. 
           
         
         (II) (a) Anisic acid -3-hydroxypropylester 
       
    
     
       
         
         
             
             
         
       
         
         
           
             (b1) at least one, two, three, four or more surfactants selected from the group consisting of Sodium Laureth Sulfate, Cocoamidopropyl Betaine, Cocomide MEA, Disodium Cocoyl Glutamate, PEG-7 Glyceryl Cocoate, Sodium Stearoyllactylate, Lauryl Glycoside, Disodium Cocoamphodiacetate, Sodium C14-16 Olefin Sulfonate, Sodium C14-17 Alkyl Sec Sulfonate, and Disodium Laureth Sulfosuccinate. 
           
         
       
    
     For clarification it should be noted that the preferred compositions should be understood as a disclosure for mixtures of the compounds (I to III) with ANY of the cited oil bodies and/or ANY of the cited emulsifiers. The cited Markush group is therefore nothing else than a simplified form of disclosing each binary or ternary combination literally. As a matter of fact, any of these binary or ternary compositions is particularly preferred, since they are capable of providing superior stabilizing properties. 
     EXAMPLES 
     The following examples were performed using 
     
       
         
         
             
             
         
       
     
     as compounds of formula (I). 
     EXAMPLE 1 
     Determination of Surface Tension (Lauda TVT2, Drop/Volume Method) 
     Surface tension of the two compounds cited above was determined at a dosage of 0.5 wt.-percent in demineralized water. The results are shown in Table 1: 
     
       
         
           
               
             
               
                 TABLE 1 
               
             
            
               
                   
               
               
                 Surface tension 
               
            
           
           
               
               
               
            
               
                   
                   
                 Surface tension σ [mN/m] 
               
            
           
           
               
               
               
               
               
            
               
                   
                   
                 Benzoic Acid  
                 Anisic Acid-3- 
                 Water  
               
               
                   
                 Run 
                 3-Hydroxypropylester 
                 Hydroxypropylester 
                 demin. 
               
               
                   
                   
               
               
                   
                 1 
                 50.81 
                 48.95 
                 69.48 
               
               
                   
                 2 
                 50.78 
                 48.92 
                 69.48 
               
               
                   
                 3 
                 50.78 
                 48.92 
                 69.46 
               
               
                   
                 ø 
                 50.79 
                 48.93 
                 69.47 
               
               
                   
                   
               
            
           
         
       
     
     The results clearly indicate that adding the compounds to water leads to a significant reduction in surface tension which indicates that the additives exhibit strong emulsification power. 
     EXAMPLE 2 
     Determination of Co-Emulsifying Properties in Model Emulsion 
     The following o/w emulsions as set out in Table 2 were preparaed according to the following protocol:
         Heat phase A and B separately to 80° C.   Add Phase B to A and emulsify (Ultra Turrrax Stirrer, 2 min, 6000 U/min)   Allow to cool by using a vane stirrer (150 U/min, 10 min, 1000/min, 10 min) pH value: 6.0       

     
       
         
           
               
             
               
                 TABLE 2 
               
             
            
               
                   
               
               
                 O/W emulsions (amounts in wt.-percent) 
               
            
           
           
               
               
               
               
               
               
               
               
               
            
               
                 Phase 
                 Component 
                 C1 
                 1 
                 2 
                 3 
                 4 
                 5 
                 6 
               
               
                   
               
               
                 A. 
                 Potassium Cetyl  
                  2.0 
                  2.0 
                  2.0 
                  2.0 
                  2.0 
                  2.0 
                  2.0 
               
               
                   
                 Phosphate, 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Hydrogenated  
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Palm Glycerides 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Cetearyl Alcohol 
                  0.7 
                  0.7 
                  0.7 
                  0.7 
                  0.7 
                  0.7 
                  0.7 
               
               
                   
                 Caprylic/Capric  
                  8.0 
                  8.0 
                  8.0 
                  8.0 
                  8.0 
                  8.0 
                  8.0 
               
               
                   
                 Triglyceride 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Cetearyl  
                  4.0 
                  4.0 
                  4.0 
                  4.0 
                  4.0 
                  4.0 
                  4.0 
               
               
                   
                 Ethylhexanoate 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Dimethicone 
                  0.1 
                  0.1 
                  0.1 
                  0.1 
                  0.1 
                  0.1 
                  0.1 
               
               
                 B. 
                 Benzoic Acid-3- 
                 — 
                  0.3 
                  0.5 
                  1.0 
                 — 
                 — 
                 — 
               
               
                   
                 droxypropylester 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Anisic Acid-3- 
                 — 
                 — 
                 — 
                 — 
                  0.3 
                  0.5 
                  1.0 
               
               
                   
                 Hydroxy- 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 propylester 
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 Water (Aqua) 
                 83.7 
                 83.4 
                 83.2 
                 82.7 
                 83.4 
                 83.2 
                 82.7 
               
               
                   
                 Glycerin 
                  1.5 
                  1.5 
                  1.5 
                  1.5 
                  1.5 
                  1.5 
                  1.5 
               
            
           
           
               
               
               
            
               
                   
                 Sum 
                 100 
               
               
                   
               
            
           
         
       
     
     Particle Size Measurements of O/W Emulsions 
     Particle size distribution was determined by using a Malvern Mastersizer MAF 500 (volume based) and a water/ethanol 90:10 mixture as the solvent.
     Obscuration: 15-20%   Pump speed: 2510 rpm   Time: 10 min   

     Table 3 provides the data for the D50 values, which means that 50% of the oil droplets are smaller than the measured value in μm. 
     
       
         
           
               
             
               
                 TABLE 3 
               
             
            
               
                   
               
               
                 Particle size distribution by D50 values 
               
            
           
           
               
               
               
               
            
               
                 Benzoic Acid 3- 
                 D50  
                 Anisic Acid-3- 
                 D50  
               
               
                 Hydroxypropylester (%) 
                 [μm] 
                 Hydroxypropylester (%) 
                 [μm] 
               
               
                   
               
               
                 Placebo 
                 7.3 
                 Placebo 
                 7.3 
               
               
                 0.3 
                 5.1 
                 0.3 
                 4.7 
               
               
                 0.5 
                 5.5 
                 0.5 
                 4.6 
               
               
                 1.0 
                 5.1 
                 1.0 
                 4.2 
               
               
                   
               
            
           
         
       
     
     The results clearly demonstrate that adding Benzoic Acid 3-Hydroxypropylester or Anisic Acid-3-Hydroxypropylester even at low concentrations of 0.3 wt.-percent the particle size distribution is shifted to smaller droplets, and thus higher stability of the o/w emulsions. 
     Results of Analytical Fotocentrifugation (Lumisizer) of Model Emulsions 
     O/W emulsions C1 and 1 to 6 were treated by using an analytical fotocentrifuge using a Lumisizer 6102-41 by Lum Corp. The conditions were as follows:
     Rotation speed: 3000 rpm   Temperature: 40° C.   Time: 1.75 h   Analysis: Extinction   

     From the data thus obtained instability indices were calculated as presented in Table 4: 
     
       
         
           
               
             
               
                 TABLE 4 
               
             
            
               
                   
               
               
                 Instability Indices 
               
            
           
           
               
               
            
               
                   
                 Instability Indices 
               
            
           
           
               
               
               
            
               
                   
                 Benzoic Acid 3- 
                 Anisic Acid-3- 
               
               
                   
                 Hydroxypropylester 
                 Hydroxypropylester 
               
               
                   
               
               
                 Placebo 
                 0.509 
                 0.509 
               
               
                 0.3 
                 0.298 
                 0.276 
               
               
                 0.5 
                 0.251 
                 0.228 
               
               
                 1.0 
                 0.230 
                 0.250 
               
               
                   
               
            
           
         
       
     
     The results clearly demonstrate that adding Benzoic Acid 3-Hydroxypropylester or Anisic Acid-3-Hydroxypropylester even at low concentrations of 0.3 wt.-percent the instability index decreases and thus stability is improved. 
     The present invention is further illustrated by the following  FIGS.  1  to  4   : 
       FIGS.  1  and  2    show emulsions with Benzoic Acid 3-Hydroxypropylester ( FIG.  1   ) Anisic Acid-3-Hydroxypropylester ( FIG.  2   ). The first tube contains an emulsion without an additive, followed from left to right by emulsions with 0.3, 0.5 and 1 wt.-percent additive. As can be seen lower amounts of water separation indicates the positive impact of the compound in terms of emulsion stability. 
       FIGS.  3  and  4    show microscopic images of model emulsions (Olympus IX 70, 60fold).  FIG.  3    refers to emulsions comprising 0.3, 0.5 and 1% Benzoic Acid 3-Hydroxypropylester and  FIG.  4    to respective emulsions with the same amounts of Anisic Acid-3-Hydroxypropylester. The first picture in both figures shows a placebo. 
     EXAMPLE 3 
     Influence of Benzoic Acid 3-Hydroxypropylester and Anisic Acid 3-Hydroxypropylester on Foam Volume and Drainage of a Surfactant Based Formulation 
     Description 
     Foam stability is an important characteristic for all surfactant based cosmetic and household formulations. Foam stability can be evaluated by measuring foam volume and drainage (draining of liquid from the foam) during time. Experiments to determine the volume of foam and drainage were performed by using an “Ernst Haage” foam tester ( FIG.  5   ). 
     Sample Preparation and Measuring of Foam Volume and Drainage 
     Benzoic Acid 3-Hydroxypropylester and Anisic Acid 3-Hydroxypropylester were incorporated 1% by weight into the described shampoo formulation according to Table 5 by stirring with a vane stirrer. 
     
       
         
           
               
             
               
                 TABLE 5 
               
             
            
               
                   
               
               
                 Shampoo formulation (amounts in w/w %, A = Placebo) 
               
            
           
           
               
               
               
               
               
               
            
               
                 P 
                 Compound 
                 INCI 
                 A 
                 B 
                 C 
               
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 A 
                 Plantacare PS10 
                 Sodium Laureth  
                 17.0 
                 17.0 
                 17.0 
               
               
                   
                   
                 Sulfate, 
                   
                   
                   
               
               
                   
                   
                 Lauryl Glycoside 
                   
                   
                   
               
               
                   
                 Citric Acid 
                 Citric Acid 
                 0.15 
                 0.15 
                 0.15 
               
               
                   
                 SymDiol 68 
                 1,2 Hexandiol,  
                 1.0 
                 1.0 
                 1.0 
               
               
                   
                   
                 Caprylyl Glycol 
                   
                   
                   
               
               
                   
                 EDTA BD 
                 Disodium EDTA 
                 0.1 
                 0.1 
                 0.1 
               
            
           
           
               
               
               
               
            
               
                 B 
                 Water. demin. 
                 Water (Auqa) 
                 Ad 100 
               
            
           
           
               
               
               
               
               
               
            
               
                   
                 Ucare Polymer  
                 Polyquaternium-10 
                 0.2 
                 0.2 
                 0.2 
               
               
                   
                 JR-400 
                   
                   
                   
                   
               
               
                 C 
                 Potassium Sorbate 
                 Potassium Sorbate 
                 0.15 
                 0.15 
                 0.15 
               
               
                 D 
                 Tego Betain F50 
                 Cocoamidoproyl  
                 5.0 
                 5.0 
                 5.0 
               
               
                   
                   
                 Betaine 
                   
                   
                   
               
               
                 E 
                 Sodium Chloride 
                 Sodium Chloride 
                 0.4 
                 0.4 
                 0.4 
               
            
           
           
               
               
               
               
               
            
               
                 F 
                 Benzoic Acid 3-Hydroxypropylester 
                 — 
                 1.0 
                 — 
               
               
                   
                 Anisic Acid 3-Hydroxypropylester 
                 — 
                 — 
                 1.0 
               
               
                   
               
            
           
         
       
     
     Preparation: Blend Phase A by stirring slowly with a vane stirrer, stop the process when foaming starts. Swell Ucare PoyInner JR-400 in water by stirring and warming up to 50° C. (The dispersion becomes clear and slightly viscous, when swelling process is completed). Add Phases B, C and D to A one after the other by stirring with a vane stirrer. pH value should be adjusted to approx. 5,4-5,8. The shampoo formulations were diluted with demineralized water to 1% (w/w) solutions (by using a vane stirrer at 50 rpm for 2 minutes). 
     200ml of these diluted formulations were transferred into the foam tester. The stamp of the instrument was pushed up and down 60 times and the volume of the resulting foam was recorded directly. The volume of drainage was measured after 0, 15, 30, 60 and 180 sec. The results from foam volume measurements and drainage measurements are shown in Tables 6 and 7: 
     
       
         
           
               
             
               
                 TABLE 6 
               
             
            
               
                   
               
               
                 Foam volume measurements 
               
            
           
           
               
               
               
            
               
                   
                   
                 Mean  
               
               
                 Measurements 
                 Sample 
                 value (ml) 
               
               
                   
               
               
                 1. Measurement A 
                 Placebo 
                 1.600 
               
               
                 2. Measurement A 
                   
                   
               
               
                 1. Measurement B 
                 +Benzoic Acid 3-Hydroxypropylester 
                 1.650 
               
               
                 2. Measurement B 
                   
                   
               
               
                 1. Measurement C 
                 +Anisic Acid 3-Hydroxypropylester 
                 1.650 
               
               
                 2. Measurement C 
               
               
                   
               
            
           
         
       
     
     Foam volume was increased by 50 ml in presence of Benzoic Acid 3-Hydroxypropylester and Anisic Acid 3-Hydroxypropylester respectively. 
     
       
         
           
               
             
               
                 TABLE 7 
               
             
            
               
                   
               
               
                 Results drainage measurements 
               
            
           
           
               
               
               
               
               
               
               
            
               
                   
                 time (sec) 
                 0 
                 15 
                 30 
                 60 
                 180 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
            
               
                 Volume of  
                 Placebo 
                 0 
                 5 
                 7.5 
                 20 
                 80 
               
               
                 drainage (ml) 
                 +Benzoic Acid  
                 0 
                 0 
                 2.5 
                 10 
                 70 
               
               
                   
                 3-Hydroxypropylester 
                   
                   
                   
                   
                   
               
               
                   
                 +Anisic Acid  
                 0 
                 0 
                 2.5 
                 7.5 
                 67.5 
               
               
                   
                 3-Hydroxypropylester 
               
               
                   
               
            
           
         
       
     
     Less drainage in presence of Benzoic Acid 3-Hydroxypropylester and Anisic Acid 3-Hydroxypropylester corresponds to better foam stability as depicted in  FIG.  6   .